
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    [{"authors":["admin"],"categories":null,"content":"I build tools and platforms that turn complex genomic data into clear insights. My work focuses on developing bioinformatics pipelines, interactive visualizations, and AI models for target discovery and mechanism-of-action understanding.\nWhat I do\nI use large language models (including Claude and GitHub Copilot) to accelerate planning and development of the platforms I lead.\nCreate interactive dashboards ‚Äì Build visualization platforms that make multi-omics data accessible for research teams and decision-makers. Build bioinformatics tools ‚Äì Develop Nextflow pipelines and custom Python and R packages for sequencing data processing. Develop AI models ‚Äì Build neural network models for drug development and target discovery. Architect cloud infrastructure ‚Äì Design scalable, reproducible computational environments on AWS for genomics workflows. Current work As Director of the Bioinformatics Platform at Harvard Chan School, I manage the core bioinformatics pipelines and lead development of interactive visualization tools for multiple research programs.\nConsulting Advisor to emerging biotech companies on computational biology strategy, data infrastructure, and bioinformatics platforms for target discovery and drug development.\nBackground Over 13 years leading computational biology teams in biotech and academia, with experience spanning fibrosis research, oncology, neurodegeneration, and xenotransplantation. Proven track record of building teams, managing cross-functional collaborations, and delivering genomic insights that drive drug discovery decisions.\nCommunity leadership\nProducer (2025‚Äìpresent) and host (2025 season) of the A Coffee with CompBio podcast with Alex Bartlett. Founder of Women in Bioinformatics Boston (2016‚Äìpresent). VP board member at AWIS MASS (2025‚Äì2026). Nextflow maintainer. ","date":-62135596800,"expirydate":-62135596800,"kind":"term","lang":"en","lastmod":-62135596800,"objectID":"2525497d367e79493fd32b198b28f040","permalink":"http://lpantano.github.io/author/","publishdate":"0001-01-01T00:00:00Z","relpermalink":"/author/","section":"authors","summary":"I build tools and platforms that turn complex genomic data into clear insights. My work focuses on developing bioinformatics pipelines, interactive visualizations, and AI models for target discovery and mechanism-of-action understanding.\n","tags":null,"title":"","type":"authors"},{"authors":null,"categories":["Tutorials"],"content":"Video Tutorial Description Reviewing 100+ papers for Health Integrity Project taught me: consistency beats speed. Custom AI commands now run identical evaluations every time‚Äîsame conflict checks, same quality criteria, same workflow.\nResult: 30min reviews, zero missed steps, reproducible standards. Works for any systematic workflow you repeat.\nhttps://decodingdata.substack.com/p/systematic-paper-reviews-with-claude\nWatch on YouTube View on YouTube\n","date":1769638816,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1769638816,"objectID":"b84ab011985693b6694b476b7d234b79","permalink":"http://lpantano.github.io/tutorials/2026-01-28-systematic-paper-reviews-with-claude-custom-commandsskills/","publishdate":"2026-01-28T22:20:16Z","relpermalink":"/tutorials/2026-01-28-systematic-paper-reviews-with-claude-custom-commandsskills/","section":"tutorials","summary":"Reviewing 100+ papers for Health Integrity Project taught me: consistency beats speed. Custom AI commands now run identical evaluations every time‚Äîsame conflict checks, same quality criteria, same wor...","tags":["tutorial","video"],"title":"Systematic Paper Reviews with Claude Custom Commands/Skills","type":"tutorial"},{"authors":[],"categories":["Data at Scale"],"content":" Note: Claude now calls custom commands ‚Äúskills‚Äù - the functionality is identical, just renamed. This post uses the original ‚Äúcustom commands‚Äù terminology from the video.\nThe Problem: Inconsistent Paper Reviews I review hundreds of scientific papers for the Health Integrity Project. We evaluate health claims‚Äîthings you hear everywhere, like ‚ÄúRed raspberry leaf shortens labor‚Äù‚Äîand determine if scientific evidence supports them.\nThe challenge? Consistency.\nManual reviews take 30 minutes to 2 hours per paper. I might check for conflicts of interest thoroughly in one review, then forget in the next. Focus on statistical methods in one paper, skip bias assessment in another. My criteria shift paper to paper.\nThis inconsistency doesn‚Äôt just waste time‚Äîit undermines scientific validity. If evaluation criteria change between papers, the entire project loses credibility.\nThe Solution: Claude Custom Commands Claude custom commands tell the AI model exactly how to handle a specific task. I created a command that runs the same evaluation workflow every single time.\nThe workflow asks:\nAre there conflicts of interest? Is this a valid study type (not narrative reviews)? Is the control group adequate? What biases exist? Do results align with the claim? Each paper goes through identical steps. Nothing gets skipped.\nHow It Works A custom command is a markdown file in your project folder (.claude/commands/). Mine is called review-paper.md.\nBasic Structure Every custom command has three parts:\nInput: What you provide Task: What Claude should do Output format: How results should look Here‚Äôs the minimal markdown structure:\n# Command Name ## Input - Item 1 (e.g., paper location) - Item 2 (e.g., claim to evaluate) ## Task Step-by-step instructions for Claude to follow ## Output Format How you want results structured My Paper Review Workflow ## Step 1: Validation Screen - Check conflict of interest - Identify study type - Flag narrative reviews or meta-analyses - Output: VALID or INVALID with reasons ## Step 2: Quality Assessment - Evaluate control groups - Assess statistical methods - Identify biases - Output: Quality rating with evidence ## Step 3: Result Alignment - Compare study results to claim - Determine if supporting or contradicting - Output: Category recommendation Real Example: Raspberry Leaf Study I run the command: /review-paper\nClaude asks for:\nPaper location Claim being evaluated Paper position (supporting or contradicting) I provide:\nPaper: raspberry-study.pdf Claim: ‚ÄúRed raspberry leaf shortens labor and helps induce birth‚Äù Position: Supporting Claude starts the evaluation:\nStep 1 Results:\nFunding: Company involvement noted, but primary funding independent Study type: Human clinical trial (valid) No narrative meta-analysis Status: Proceed to quality check Step 2 Results:\nControl group: Present Statistical methods: Adequate sample size, appropriate tests Biases: Selection bias possible (self-reported outcomes) Step 3 Results:\nStudy results: No significant difference in labor duration Alignment with claim: CONTRADICTS Category: Misinformation (claim unsupported by results) At each step, I can interact: ‚ÄúDig deeper into selection bias‚Äù or ‚ÄúShow exact quote about labor duration from paper.‚Äù\nBeyond Paper Reviews Custom commands work for any repeated workflow.\nExample for bioinformatics:\nCommand: /optimize-nextflow Input: Pipeline directory Task: 1. Analyze resource usage from execution reports 2. Calculate actual vs requested CPU/memory 3. Ignore failed jobs 4. Generate updated resource config 5. Optional: Update nextflow.config Output: Resource optimization recommendations Why This Matters Time savings: Reviews that took 1-2 hours now take 30 minutes.\nConsistency: Same questions, same order, every paper.\nThoroughness: Nothing gets forgotten or skipped.\nTransparency: The workflow is documented and repeatable.\nThe custom command doesn‚Äôt replace my judgment‚Äîit retrieves information and ensures I evaluate every paper the same way. I still make final decisions. I still dig deeper when needed.\nWhat custom commands can‚Äôt do: Make subjective quality judgments, understand context outside the paper, or catch every nuance in complex statistical methods. They work best for structured, repeatable workflows where the steps are clear.\nBut I never miss conflict of interest checks again. I never forget to assess control groups. The baseline evaluation happens consistently.\nGetting Started Find a workflow you repeat frequently Document the steps Define input, task, and output format Create a markdown file in .claude/commands/ Test and refine Start simple. Even basic workflows benefit from automation.\nThe goal isn‚Äôt to hand everything to AI. It‚Äôs to ensure your systematic processes stay systematic.\nResources:\nHealth Integrity Project - Evidence-based health claim evaluation Claude Custom Commands/skills Documentation - How to create your own commands Health Integrity Review Workflow - Our paper evaluation process Have you tried custom ‚Ä¶","date":1769616000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1769616000,"objectID":"2c02e1fd265580ca33bb995fc5a46116","permalink":"http://lpantano.github.io/post/2026/2026-01-28-claude-custom-commands-paper-review/","publishdate":"2026-01-28T12:00:00-04:00","relpermalink":"/post/2026/2026-01-28-claude-custom-commands-paper-review/","section":"post","summary":"Custom AI commands ensure consistent scientific paper reviews. Learn to automate any repeated workflow while maintaining quality and thoroughness through systematic evaluation.","tags":["AI-automation","research-workflows","scientific-computing","paper-review","bioinformatics","reproducibility"],"title":"Systematic Paper Reviews with Claude Custom Commands","type":"post"},{"authors":null,"categories":["Tutorials"],"content":"Video Tutorial Description Read Post: https://lpantano.github.io/post/2026/2026-01-16-igv-cloud-visualization/ Subscribe: https://decodingdata.substack.com/s/data-at-scale\nYou just ran a genomic pipeline that generated 50GB of BAM files in the cloud. Now you need to check alignment quality. Do you really have to download everything to run IGV locally? Switch virtual machines to load the files? Write code to generate static visuals?\nThis integration brings IGV directly to your cloud workspace with automatic track discovery. It scans your storage, finds all genomic files, and presents them in a ready-to-load menu. No downloads, no file paths, no manual configuration.\nWatch on YouTube View on YouTube\n","date":1769031727,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1769031727,"objectID":"cd99f19d7bf4a959eb53d5350419767b","permalink":"http://lpantano.github.io/tutorials/2026-01-21-bringing-igv-webapp-to-your-cloud-workspace-in-seqera/","publishdate":"2026-01-21T21:42:07Z","relpermalink":"/tutorials/2026-01-21-bringing-igv-webapp-to-your-cloud-workspace-in-seqera/","section":"tutorials","summary":"Read Post: https://lpantano.github.io/post/2026/2026-01-16-igv-cloud-visualization/ Subscribe: https://decodingdata.substack.com/s/data-at-scale You just ran a genomic pipeline that generated 50GB of ...","tags":["tutorial","video"],"title":"Bringing IGV webapp to Your Cloud Workspace in Seqera","type":"tutorial"},{"authors":[],"categories":["Data at Scale"],"content":"You just ran a genomic pipeline that generated 50GB of BAM files in the cloud. Now you need to check alignment quality. Do you really have to download everything to run IGV locally? Switch virtual machines to load the files? Write code to generate static visuals?\nThis integration brings IGV directly to your cloud workspace with automatic track discovery. It scans your storage, finds all genomic files, and presents them in a ready-to-load menu. No downloads, no file paths, no manual configuration.\nThe Workflow Gap Analysis happens in the cloud. Fast compute, scalable storage, pipelines that finish overnight.\nVisualization happens separately or requires coding. Manual downloads or transfers, disk space constraints, waiting for transfers to complete, changing environments.\nThis gap slows iteration. It wastes time. And it‚Äôs fixable.\nWhat Cloud-Native Visualization Looks Like I built an integration that runs IGV as a web app directly in Seqera workspaces. It connects to the same cloud storage your pipelines write to. It automatically discovers all genomic files. Zero downloads, zero manual file loading.\nOther solutions exist‚Äîdesktop IGV in Studios or Python notebooks for programmatic visualization. These work, but they‚Äôre not seamless. Desktop IGV still requires manual file path configuration. Notebooks require coding for every view. This approach eliminates both friction points.\nHow It Works The container combines IGV web app with Seqera‚Äôs connect-client. The connect-client uses FUSE to mount cloud storage, making remote files appear local to IGV.\nA startup script scans mounted directories for genomic files‚ÄîBAM, CRAM, VCF, BED, BigWig, anything IGV can read. It detects file formats, checks for index files, and generates a track catalog. IGV reads this catalog and populates a custom ‚ÄúAuto-discovered Tracks‚Äù menu.\nThe visualization tool comes to where data already lives.\nWhat This Looks Like in Practice Launch the IGV Studio from your Seqera interface. Your browser opens with the IGV web app.\nClick Tracks ‚Üí Auto-discovered Tracks. See a table of all your BAM files, VCF variants, coverage tracks‚Äîeverything in your mounted storage.\nClick to load. Instant visualization.\nWhy This Matters Skip the download/coding wait. Checking alignments after a pipeline run no longer means waiting to transfer data or coding.\nStop duplicating storage. No local copies means hundreds of GB saved per researcher.\nShare results faster. Send a browser URL instead of transferring massive files.\nOnboard easier. New team members don‚Äôt need complex local setups. They click a link and start viewing data.\nImprove reproducibility. Everyone views the same authoritative data source in cloud storage, not their own potentially outdated local copies.\nGetting Started Important context: This solution is specifically for Seqera Platform users. If you‚Äôre using other platforms like Terra, AnVIL, Galaxy, or DNAnexus, they have their own approaches to interactive visualization. This implementation leverages Seqera‚Äôs Studios feature and connect-client architecture.\nThe full implementation is open source in the Seqera custom studios examples repository. You‚Äôll find:\nComplete Dockerfile with multi-stage build Automatic track discovery script Deployment documentation Configuration examples Maturity note: This is a proof of concept tested on several datasets. It demonstrates the pattern and should help you get started, but expect to adapt it for production use. Test thoroughly with your own data and file structures.\nThe code is customizable. Adapt the track discovery logic for your file naming conventions. Change the reference genome. Add authentication if needed.\nThe Broader Pattern Cloud-native analysis means rethinking entire workflows, not just moving compute. Bringing visualization to cloud data is part of that shift.\nOther platforms (Terra, AnVIL) mount cloud storage for interactive apps too. What makes this useful is the automatic track discovery‚Äîmost solutions require manual file paths.\nThe less time you spend moving data around, the more time you spend understanding it.\nReferences:\nRobinson JT, et al. (2011). Integrative genomics viewer. Nature Biotechnology 29(1):24-26. DOI: 10.1038/nbt.1754 IGV Web App Documentation Seqera Studios Documentation Implementation Repository ","date":1768579200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1768579200,"objectID":"3ce984bd5927141412d2e2d9332a9c72","permalink":"http://lpantano.github.io/post/2026/2026-01-16-igv-cloud-visualization/","publishdate":"2026-01-16T12:00:00-04:00","relpermalink":"/post/2026/2026-01-16-igv-cloud-visualization/","section":"post","summary":"Run IGV directly in your cloud workspace with automatic track discovery. Eliminate downloads and view genomic data where it lives. Open source proof of concept for Seqera Platform users.","tags":["bioinformatics","cloud-computing","data-pipelines","genomics","visualization","workflow-optimization"],"title":"Bringing IGV webapp to Your Cloud Workspace in Seqera","type":"post"},{"authors":[],"categories":["Data in Your Life"],"content":"I finished another easy run and checked my Garmin. Orange zone. Again.\nMy cadence sat around 157 steps per minute. The color warned me something was off. Too slow. Below average. Less experienced.\nBut I felt fine. No pain. Sustainable pace with moderate effort. So what was the problem?\nI dug into Garmin‚Äôs manual to find out. I discovered that, again, I was missing a lot of context to understand this metric.\nThe Colors Are Percentile Rankings Here‚Äôs what Garmin‚Äôs cadence zones actually mean:\nPurple (\u0026gt;183 spm): Top 5% of all Garmin users Blue (174-183 spm): 70th-95th percentile Green (164-173 spm): 30th-69th percentile (‚Äúaverage‚Äù) Orange (153-163 spm): 5th-29th percentile (‚Äúless experienced or slower‚Äù) Red (\u0026lt;153 spm): Bottom 5% My orange zone meant I ranked in the 5th-29th percentile compared to other Garmin users.\nNot that my cadence was wrong for my body. Not that I was injured or inefficient. Just that most other Garmin users run with higher cadence.\nThese aren‚Äôt personalized to your body. They‚Äôre fixed thresholds based on population data. The same thresholds apply whether you‚Äôre 5\u0026#39;4\u0026#34; or 6\u0026#39;4\u0026#34;, running easy or racing, experienced or brand new.\nThe zones compare you to everyone else. They don‚Äôt tell you what‚Äôs optimal for you.\nWhat Research Actually Shows I kept digging. Here‚Äôs what the research says about cadence:\nHalf of Cadence Is Just You Researchers modeled cadence using leg length, running speed, weight, age, and running experience in 138 youth long-distance runners. These factors explained only 48-55% of the variation between runners (Taylor-Haas et al., 2022, Gait \u0026amp; Posture).\nThe other ~50%? Unmeasurable individual factors unique to each person‚Äîlikely including tendon stiffness, muscle fiber length, and muscle group strength patterns that can‚Äôt be easily measured.\nElite ultramarathon runners show this clearly. A 2019 study of the top finishers at a 100-km World Championship found cadences ranging from 155 to 203 steps per minute‚Äîan average of 182 spm (Burns et al., 2019, Journal of Applied Physiology).\nSame performance level. 48-step difference in cadence.\nHeight and Leg Length Matter The same study found that leg length and running speed together explained approximately 50% of cadence variance (Taylor-Haas et al., 2022). Shorter leg lengths and faster running speeds were both associated with higher cadence.\nThe numbers:\nEvery inch of height = ~3 fewer steps per minute A 6-foot runner naturally takes ~18 fewer steps per minute than a 5\u0026#39;6\u0026#34; runner Longer legs = lower leg stiffness = naturally lower cadence Researchers even created a formula: Cadence = -1.251 √ó Leg Length (cm) + 3.665 √ó Speed (m/s) + 254.858\nCalculate your expected cadence:\nLeg Length (cm): Measure from hip joint to floor while standing Running Speed (m/s): Easy pace: 2.0-2.5 m/s | Tempo: 3.0-3.5 m/s | Race: 3.5+ m/s Calculate\nYour Expected Cadence: Remember, about 50% of cadence variance comes from leg length and running speed. The rest is individual. And this formula comes from one paper and is a guide to help you understand how different factors can affect cadence.\nSpeed Changes Your Cadence Your cadence at easy pace differs from your cadence at tempo pace. Obviously.\nA 2025 study of 30 experienced recreational runners (running 24+ km/week) examined how cadence changed with running speed. The study confirmed that increasing speed directly increases cadence (Leacox et al., 2025, International Journal of Sports Physical Therapy).\nSame runners. Different paces. Different cadences. But there were some exceptions where runners did not increase cadence after a certain point, even as speed increased.\nGarmin‚Äôs zones don‚Äôt distinguish between easy runs and hard efforts. An orange zone on an easy day doesn‚Äôt mean the same thing as orange on a tempo run.\nHere‚Äôs my association between cadence and speed. The correlation is clear, though there‚Äôs still variability at the same cadence. I ran in different terrains, different shoes, while sick, and while feeling fine.\nThe 180 Myth Lives On You‚Äôve probably heard it: 180 steps per minute is the ‚Äúideal‚Äù cadence.\nGarmin‚Äôs purple zone starts at 183 spm, and mentions it in the explanatory text of the graph as an ideal target.\nI won‚Äôt dive into the full story of where 180 came from‚Äîthat would take us down a rabbit hole of observations, elite athletes, and how one number became running gospel. But here‚Äôs what matters: research shows it doesn‚Äôt apply to everyone.\nElite ultramarathoners performing at the same level run with cadences ranging from 155 to 203 steps per minute (Burns et al., 2019). That‚Äôs a 48-step difference. Same performance. Wildly different cadences.\nThe 180 rule came from watching elite runners at race pace. Not recreational runners. Not easy pace. Not different body types.\nYet somehow it became the standard everyone chases.\nWhat This Means for You Ignore the colors.\nOrange doesn‚Äôt mean you‚Äôre doing something wrong. Especially if you‚Äôre tall, running easy pace, or simply built differently from ‚Ä¶","date":1768320000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1768320000,"objectID":"0a136e427f90646530601551aa00fb74","permalink":"http://lpantano.github.io/post/2026/2026-01-running-cadence-myth/","publishdate":"2026-01-13T12:00:00-04:00","relpermalink":"/post/2026/2026-01-running-cadence-myth/","section":"post","summary":"Garmin's cadence color zones are percentile rankings, not personal optimization. Here's what those orange and red zones actually mean‚Äîand when you should worry.","tags":["running","data literacy","fitness tracking","wearable technology","sports science"],"title":"What Your Running Watch Isn't Telling You About Cadence","type":"post"},{"authors":null,"categories":["Bioinformatics"],"content":"Overview A collection of code templates and training materials for performing downstream analysis following single-cell RNA preprocessing. This repository provides standardized workflows for researchers working with scRNA-seq data, from quality assessment to differential expression.\nView Documentation ‚Üí | GitHub Repository ‚Üí\nKey Features Quality Assessment: Templates for evaluating scRNA and scATAC data quality Integration Analysis: Workflows for combining multiple samples with batch effect correction Differential Expression: Multiple approaches including pseudobulk analysis via DESeq2 and MAST methodology Compositional Analysis: Methods for examining cell-type abundance changes across conditions Gene Imputation: Techniques using ALRA and MAGIC algorithms to address data sparsity Pipeline Integration: Support for nf-core scrnaseq pipeline outputs and standalone Cell Ranger processing Technical Stack Built primarily in R with supporting shell scripts:\nSeurat for single-cell data handling and analysis DESeq2 for differential expression analysis Harmony for batch effect correction nf-core scrnaseq pipeline integration Quarto and R Markdown for reproducible reports What It Provides The repository includes:\nReady-to-use analysis templates for common scRNA-seq tasks Training materials and documentation Standardized workflows following best practices Integration with popular preprocessing pipelines Examples for both scRNA-seq and scATAC-seq data Development Status Templates are labeled with revision tiers:\nStable: Fully tested and production-ready Alpha: Functional but requires additional testing Draft: Under active development, may need manual parameter tuning Why This Matters Single-cell RNA-seq analysis requires specialized knowledge and tools. This project:\nReduces the learning curve for new single-cell researchers Provides validated workflows following community best practices Enables reproducible analysis through standardized templates Supports multiple experimental designs and research questions Integrates seamlessly with popular preprocessing pipelines For more information or to contribute, visit the GitHub repository or explore the documentation.\n","date":1768262400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1768262400,"objectID":"63acee1b39d85998c775d0dc50910037","permalink":"http://lpantano.github.io/portfolio/singlecell-reports/","publishdate":"2026-01-13T00:00:00Z","relpermalink":"/portfolio/singlecell-reports/","section":"portfolio","summary":"Code templates and training materials for single-cell RNA-seq downstream analysis","tags":["Bioinformatics","Single-Cell","Visualization"],"title":"Single-Cell RNA-Seq Analysis Reports","type":"portfolio"},{"authors":null,"categories":null,"content":"A collection of code templates and training materials for performing downstream analysis following single-cell RNA preprocessing. This repository provides standardized workflows for researchers working with scRNA-seq data, from quality assessment to differential expression.\nView Documentation ‚Üí | GitHub Repository ‚Üí\nKey Features Quality Assessment: Templates for evaluating scRNA and scATAC data quality Integration Analysis: Workflows for combining multiple samples with batch effect correction Differential Expression: Multiple approaches including pseudobulk analysis via DESeq2 and MAST methodology Compositional Analysis: Methods for examining cell-type abundance changes across conditions Gene Imputation: Techniques using ALRA and MAGIC algorithms to address data sparsity Pipeline Integration: Support for nf-core scrnaseq pipeline outputs and standalone Cell Ranger processing Technical Stack Built primarily in R with supporting shell scripts:\nSeurat for single-cell data handling and analysis DESeq2 for differential expression analysis Harmony for batch effect correction nf-core scrnaseq pipeline integration Quarto and R Markdown for reproducible reports What It Provides The repository includes:\nReady-to-use analysis templates for common scRNA-seq tasks Training materials and documentation Standardized workflows following best practices Integration with popular preprocessing pipelines Examples for both scRNA-seq and scATAC-seq data Development Status Templates are labeled with revision tiers:\nStable: Fully tested and production-ready Alpha: Functional but requires additional testing Draft: Under active development, may need manual parameter tuning Why This Matters Single-cell RNA-seq analysis requires specialized knowledge and tools. This project:\nReduces the learning curve for new single-cell researchers Provides validated workflows following community best practices Enables reproducible analysis through standardized templates Supports multiple experimental designs and research questions Integrates seamlessly with popular preprocessing pipelines For more information or to contribute, visit the GitHub repository or explore the documentation.\n","date":1768262400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1768262400,"objectID":"ff657eca5039077a3300383a0af69bc1","permalink":"http://lpantano.github.io/project/singlecell-reports/","publishdate":"2026-01-13T00:00:00Z","relpermalink":"/project/singlecell-reports/","section":"project","summary":"Code templates and training materials for single-cell RNA-seq downstream analysis","tags":["Bioinformatics","Single-Cell","Visualizations"],"title":"Single-Cell RNA-Seq Analysis Reports","type":"project"},{"authors":null,"categories":["Bioinformatics"],"content":"Overview A template repository providing analysis workflows for spatial single-cell transcriptomics data across multiple experimental platforms and analytical packages. This project offers researchers standardized pipelines for quality control, clustering, and cell-type annotation.\nView on GitHub ‚Üí\nKey Features Multi-Platform Support: Templates for COSMX and Visium[HD] spatial transcriptomics platforms Quality Control Pipelines: Comprehensive QC assessment workflows for data validation Clustering Workflows: Spatial clustering using Banksy and other established tools Cell-Type Annotation: Integration with spacexr for cell-type identification and differential expression Reproducible Environment: RStudio Projects with renv package management for dependency control Technical Stack Built entirely in R with integration of leading bioinformatics tools:\nSeurat for Visium object handling Banksy for spatial clustering analysis spacexr for cell-type identification Quarto and R Markdown for report generation What It Provides The repository includes:\nReady-to-use analysis templates Downloadable test data for learning and validation Dependency installation scripts Quick-start documentation for RStudio users Standardized workflows across different spatial platforms Development Status Projects are labeled with revision tiers:\nStable: Fully tested and production-ready Alpha: Functional but requires additional testing Draft: Under active development, may need manual parameter tuning Why This Matters Spatial transcriptomics generates complex data requiring specialized analysis approaches. This project:\nReduces setup time for new spatial transcriptomics projects Provides validated workflows following best practices Enables reproducible research through standardized templates Lowers the barrier to entry for spatial data analysis Maintains consistency across different experimental platforms For more information or to contribute, visit the GitHub repository.\n","date":1768262400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1768262400,"objectID":"5171f23ff5936e9907d4981eaead1213","permalink":"http://lpantano.github.io/portfolio/spatial-reports/","publishdate":"2026-01-13T00:00:00Z","relpermalink":"/portfolio/spatial-reports/","section":"portfolio","summary":"Template repository for spatial single-cell transcriptomics data analysis workflows","tags":["Bioinformatics","Spatial Transcriptomics","Visualization"],"title":"Spatial Transcriptomics Analysis Reports","type":"portfolio"},{"authors":null,"categories":null,"content":"A template repository providing analysis workflows for spatial single-cell transcriptomics data across multiple experimental platforms and analytical packages. This project offers researchers standardized pipelines for quality control, clustering, and cell-type annotation.\nView on GitHub ‚Üí\nKey Features Multi-Platform Support: Templates for COSMX and Visium[HD] spatial transcriptomics platforms Quality Control Pipelines: Comprehensive QC assessment workflows for data validation Clustering Workflows: Spatial clustering using Banksy and other established tools Cell-Type Annotation: Integration with spacexr for cell-type identification and differential expression Reproducible Environment: RStudio Projects with renv package management for dependency control Technical Stack Built entirely in R with integration of leading bioinformatics tools:\nSeurat for Visium object handling Banksy for spatial clustering analysis spacexr for cell-type identification Quarto and R Markdown for report generation What It Provides The repository includes:\nReady-to-use analysis templates Downloadable test data for learning and validation Dependency installation scripts Quick-start documentation for RStudio users Standardized workflows across different spatial platforms Development Status Projects are labeled with revision tiers:\nStable: Fully tested and production-ready Alpha: Functional but requires additional testing Draft: Under active development, may need manual parameter tuning Why This Matters Spatial transcriptomics generates complex data requiring specialized analysis approaches. This project:\nReduces setup time for new spatial transcriptomics projects Provides validated workflows following best practices Enables reproducible research through standardized templates Lowers the barrier to entry for spatial data analysis Maintains consistency across different experimental platforms For more information or to contribute, visit the GitHub repository.\n","date":1768262400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1768262400,"objectID":"1f119aa39a56a7dc191bafd380db47bc","permalink":"http://lpantano.github.io/project/spatial-reports/","publishdate":"2026-01-13T00:00:00Z","relpermalink":"/project/spatial-reports/","section":"project","summary":"Template repository for spatial single-cell transcriptomics data analysis workflows","tags":["Bioinformatics","Spatial Transcriptomics","Visualizations"],"title":"Spatial Transcriptomics Analysis Reports","type":"project"},{"authors":null,"categories":["Tutorials"],"content":"Video Tutorial Description Job searching is already exhausting enough without spending hours customizing every application, researching every company, and second-guessing every follow-up email.\nSo in this video, we‚Äôre diving into something really practical: how to use AI as your personal interview prep assistant.\nLorena interviews Lina about her AI-powered process‚Äîfrom the moment she sees a job posting to after the interview is over. This isn‚Äôt theoretical advice. These are the actual strategies Lina is using right now during her active job search to:\n‚úÖ Cut application prep time from an hour to 20 minutes ‚úÖ Show up to interviews with strategic questions tailored to each specific interviewer ‚úÖ Research companies and roles more thoroughly than anyone could manually ‚úÖ Process interview feedback and build professional networks systematically\nWatch on YouTube View on YouTube\n","date":1768076654,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1768076654,"objectID":"98a18686456c63dc78a392ea2aa3c23e","permalink":"http://lpantano.github.io/tutorials/2026-01-10-wld-e6-ai-for-interviews/","publishdate":"2026-01-10T20:24:14Z","relpermalink":"/tutorials/2026-01-10-wld-e6-ai-for-interviews/","section":"tutorials","summary":"Job searching is already exhausting enough without spending hours customizing every application, researching every company, and second-guessing every follow-up email. So in this video, we're diving in...","tags":["tutorial","video"],"title":"WLD E6 AI for Interviews","type":"tutorial"},{"authors":null,"categories":["Tutorials"],"content":"Video Tutorial Description Hey everyone!\nLorena and I just finished recording something we WISH we‚Äôd had when we were starting out: a comprehensive guide to nailing bioinformatics interviews for junior to intermediate roles.\nHere‚Äôs the thing: bioinformatics interviews are uniquely challenging because you‚Äôre expected to demonstrate expertise across multiple domains‚Äîbiology, computer science, AND statistics‚Äîwhile also proving you can communicate clearly across all of them. It‚Äôs a lot. And most people prepare by trying to memorize every tool and algorithm, which honestly isn‚Äôt what interviewers are looking for.\nWatch on YouTube View on YouTube\n","date":1768076623,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1768076623,"objectID":"28233826711b8a6fb303752d05309d2e","permalink":"http://lpantano.github.io/tutorials/2026-01-10-wld-e5-bioinformatics-interviews-decoded/","publishdate":"2026-01-10T20:23:43Z","relpermalink":"/tutorials/2026-01-10-wld-e5-bioinformatics-interviews-decoded/","section":"tutorials","summary":"Hey everyone! Lorena and I just finished recording something we WISH we'd had when we were starting out: a comprehensive guide to nailing bioinformatics interviews for junior to intermediate roles. He...","tags":["tutorial","video"],"title":"WLD E5 Bioinformatics Interviews Decoded","type":"tutorial"},{"authors":null,"categories":["Tutorials"],"content":"Video Tutorial Description Allyship isn‚Äôt passive‚Äîit requires specific, intentional actions in the moments that matter.\nIn this video, Lorena and I break down the practical strategies for amplifying underrepresented voices in professional settings. We‚Äôre talking about real, in-the-moment tactics you can use:\n‚úÖ How to redirect attention when good ideas get talked over ‚úÖ Strategic ways to prep colleagues before high-stakes meetings ‚úÖ What to say (exactly) when you need to create space for others ‚úÖ How to use your social capital without being performative\nThis isn‚Äôt about grand gestures‚Äîit‚Äôs about the small, consistent actions that actually move the needle. Whether you‚Äôre in a position of privilege or you‚Äôre figuring out how to advocate for yourself, these strategies work.\nAs always, your support makes this content possible. Thanks for being here.\nLina \u0026amp; Lorena\nWatch on YouTube View on YouTube\n","date":1768076572,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1768076572,"objectID":"91deb0984bfb0f28d2d1b85214ad9e9a","permalink":"http://lpantano.github.io/tutorials/2026-01-10-wld-e4-amplifying-minorities/","publishdate":"2026-01-10T20:22:52Z","relpermalink":"/tutorials/2026-01-10-wld-e4-amplifying-minorities/","section":"tutorials","summary":"Allyship isn't passive‚Äîit requires specific, intentional actions in the moments that matter. In this video, Lorena and I break down the practical strategies for amplifying underrepresented voices in p...","tags":["tutorial","video"],"title":"WLD E4 Amplifying Minorities","type":"tutorial"},{"authors":null,"categories":["Tutorials"],"content":"Video Tutorial Description Most of us learned how to do our jobs, but nobody taught us how to actually work with our managers. And here‚Äôs the thing: your relationship with your manager can be the difference between feeling stuck and advancing your career ‚Äì but only if you understand what‚Äôs really going on in their world.\nThis video flips the script on how you think about your manager. Instead of seeing them as someone who just assigns tasks or approves time off, we‚Äôre showing you how to think of them as your business partner. Because when you understand their pressures, priorities, and what success looks like for them, you can position yourself as someone who makes their life easier ‚Äì and that‚Äôs when doors start opening for you.\nLina \u0026amp; Lorena\nWatch on YouTube View on YouTube\n","date":1768076505,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1768076505,"objectID":"db65336a5b39dda8d85fd6118046fea1","permalink":"http://lpantano.github.io/tutorials/2026-01-10-wld-3-understanding-your-managers-world/","publishdate":"2026-01-10T20:21:45Z","relpermalink":"/tutorials/2026-01-10-wld-3-understanding-your-managers-world/","section":"tutorials","summary":"Most of us learned how to do our jobs, but nobody taught us how to actually work with our managers. And here's the thing: your relationship with your manager can be the difference between feeling stuc...","tags":["tutorial","video"],"title":"WLD 3 Understanding Your Managers World","type":"tutorial"},{"authors":null,"categories":["Tutorials"],"content":"Video Tutorial Description You know that colleague who turns every conversation into a complaint session? Or the team meeting that devolves into gossip and finger-pointing?\nWe‚Äôve all been there. And here‚Äôs what nobody tells you: you don‚Äôt have to fix it, but you do need a strategy to handle it.\nIn this video, we break down:\nWhy you‚Äôre not responsible for being everyone‚Äôs emotional dumping ground\nThe 3-step framework for handling chronic complainers (without being dismissive)\nHow to redirect gossip and drama toward actual solutions\nThe language that transforms negative energy in real-time\nHow to set boundaries that protect your own mental space\nThe reality? Negativity spreads like wildfire in workplaces. But the good news is that positivity is just as contagious‚Äîwhen you know how to lead it.\nThis isn‚Äôt about toxic positivity or pretending problems don‚Äôt exist. It‚Äôs about separating legitimate work issues from drama, and knowing exactly what to say when someone starts spiraling.\n‚ÄîLina \u0026amp; Lorena\nWatch on YouTube View on YouTube\n","date":1768076365,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1768076365,"objectID":"9ab9ea65a10fa1f68aaa5cca1b542282","permalink":"http://lpantano.github.io/tutorials/2026-01-10-wld-2-workplace-negativity/","publishdate":"2026-01-10T20:19:25Z","relpermalink":"/tutorials/2026-01-10-wld-2-workplace-negativity/","section":"tutorials","summary":"You know that colleague who turns every conversation into a complaint session? Or the team meeting that devolves into gossip and finger-pointing? We've all been there. And here's what nobody tells you...","tags":["tutorial","video"],"title":"WLD 2 Workplace Negativity","type":"tutorial"},{"authors":null,"categories":["Tutorials"],"content":"Video Tutorial Description Welcome to our first episode! Today we‚Äôre diving into something that sounds deceptively simple but is genuinely career-changing: keeping a weekly log of your wins and quantifying your achievements. This isn‚Äôt just for performance review season (though it‚Äôs a lifesaver then) ‚Äì it‚Äôs your secret weapon for fighting imposter syndrome, building an impressive resume, and having concrete evidence ready when it‚Äôs time to negotiate that raise. Five minutes every Friday. That‚Äôs all it takes.\nWe‚Äôve created a one-page Quick Reference Guide (download below!) that you can print and keep at your desk. It covers why this matters, what to log, how to quantify your impact with real before/after examples, and practical setup tips. No more scrambling to remember what you accomplished six months ago. No more underselling yourself because you forgot the numbers. Just a simple habit that pays dividends for years to come.\nWatch the video, grab your guide, and start your first weekly win log this Friday. Seriously ‚Äì set that 5-minute calendar reminder right now. Your future self (especially the one negotiating salary or updating their resume) will thank you. Drop a comment and let us know what system you‚Äôre using ‚Äì Notion? Google Doc? Notes app? We‚Äôd love to hear what works for you!\nHappy logging! üìä ‚Äì Lorena \u0026amp; Lina\nWatch on YouTube View on YouTube\n","date":1768076277,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1768076277,"objectID":"a89905b8d52e49a7962bb044765d2643","permalink":"http://lpantano.github.io/tutorials/2026-01-10-wld-1-weekly-log/","publishdate":"2026-01-10T20:17:57Z","relpermalink":"/tutorials/2026-01-10-wld-1-weekly-log/","section":"tutorials","summary":"Welcome to our first episode! Today we're diving into something that sounds deceptively simple but is genuinely career-changing: keeping a weekly log of your wins and quantifying your achievements. Th...","tags":["tutorial","video"],"title":"WLD 1   Weekly Log","type":"tutorial"},{"authors":[],"categories":[],"content":"Last Friday, I had the chance to join a panel discussion on advancing diversity in challenging times. I was lucky to be joined by two brilliant next-gen scientists, Francince Camacho and Saba Nafees. Follow them‚Äîthey‚Äôre going to be incredible leaders and influencers in our field and beyond.\nThe session was private, intentionally, to create a safe space where we could speak openly. That setup mattered. I‚Äôve been advocating for equal opportunities since I started in science 15 years ago, and this discussion hit close to home. It‚Äôs a topic I never get tired of thinking about‚Äîbecause each time, I learn something new.\nBefore diving into my takeaways, I want to give a big shout-out to the Nextflow Summit. It was one of the most welcoming events I‚Äôve attended: committed to diversity, showcasing a wide range of voices (check out the speakers and keynotes!), and even organizing a hackathon with enough women to make me feel right at home‚Äîwhich, believe me, is rare in tech spaces. It‚Äôs such a relief to be in a room and not feel like you‚Äôre the only one representing a group.\nHere‚Äôs something I want to be clear about: we don‚Äôt need any kind of special treatment to be in this field. Bioinformatics doesn‚Äôt come with a gender requirement. What we do need is equal treatment.\nThe reasons some of us don‚Äôt come back to conferences or workplaces? It‚Äôs not complicated. Sexual comments (which somehow still happen and are still not funny), being talked over, or hearing one of our ideas repeated back to us‚Äîby someone else claiming it as their own. Yep, that still happens.\nWe no longer need to prove that diversity makes science better‚Äîthere‚Äôs already plenty of research on that. Honestly, we all just want a fair shot. Equal opportunities to work hard and be recognized. If you don‚Äôt see the inequality, that‚Äôs okay, but science has shown it‚Äôs real. Yes, things have improved. But leadership roles are still very male-dominated see LeanIn.org for stats. I won‚Äôt go into a long rant‚Äîbut if you think there‚Äôs a reason beyond unconscious bias or unequal opportunities to explain this gap, I dare you: send me a scientifically backed explanation. I‚Äôm all ears.\nAt this point, you might be feeling one of a few things:\nYou‚Äôre a man‚Äîmaybe even a white man‚Äîand you‚Äôve had a hard time too, maybe even felt discriminated against. First, I‚Äôm sorry. That sucks, and I know what that feels like. But that doesn‚Äôt mean your experience is representative of the average. On average, women still face more barriers. Let‚Äôs work together so that no one gets left out or mistreated. You‚Äôre a man who‚Äôs never seen any of this happen. Great‚Äîhappy for you! Now go ask your female coworkers what they‚Äôve experienced. This all makes sense to you. Or‚Ä¶ you think this is all BS and everything‚Äôs fine. If that‚Äôs the case, you‚Äôve probably stopped reading by now. So what can we do?\nThere‚Äôs one simple, powerful thing every ally can do‚Äîand if even 1 in 5 people with privilege did it, things would improve fast:\nAt work, be a good colleague to a woman. Then ask her, ‚ÄúHow can I support your career?‚Äù And then‚Äîtry to do it.\nThat‚Äôs it. You‚Äôd be surprised how little it takes to make a big difference. But I‚Äôll be honest‚Äîit might not be ‚Äúcomfortable.‚Äù You might have to stand up in front of other colleagues. And then two things will happen:\nSome coworkers will join you. Others might see you as that person‚Äîan annoying advocate‚Äîand you may lose a bit of their privileged support. This is where it gets real. You‚Äôll have to choose: what kind of career, and what kind of world, do you want to help build?\nBut here‚Äôs the thing: the more people who speak up, the less risky it becomes for any one person. Quiet support and private ‚Äúlikes‚Äù aren‚Äôt enough anymore. We need action. Especially from men. Now more than ever.\nNo one has ever asked me how they could help support my career. Not once.\nSo if you‚Äôre one of the people deciding to do something‚Äîthank you. Really. Welcome to the community. Let‚Äôs keep moving forward, together.\n","date":1747756800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1747756800,"objectID":"a462fce834e76d1f555dac6eb826ff23","permalink":"http://lpantano.github.io/post/2025/2025-05-diversity-panel/","publishdate":"2025-05-20T12:00:00-04:00","relpermalink":"/post/2025/2025-05-diversity-panel/","section":"post","summary":"Last Friday, I had the chance to join a panel discussion on advancing diversity in challenging times. I was lucky to be joined by two brilliant next-gen scientists, Francince Camacho and Saba Nafees. Follow them‚Äîthey‚Äôre going to be incredible leaders and influencers in our field and beyond.\n","tags":[],"title":"Beyond the Pipeline: Advancing Diversity in Challenging Times","type":"post"},{"authors":["Nextflow","Lorena Pantano"],"categories":null,"content":"","date":1747336500,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1747336500,"objectID":"f25622deb931c0b2df5822a763e58c1c","permalink":"http://lpantano.github.io/talk/nextflow2025/","publishdate":"2025-05-15T14:15:00-05:00","relpermalink":"/talk/nextflow2025/","section":"talk","summary":"Biomedical research generates complex, large-scale data that presents challenges in manipulation, storage, distribution, and analysis, particularly for non-computational biologists. Advancements in sequencing technologies, including single-cell and spatial biology, have transformed biological research approaches. The increasing volume and complexity of sequencing data necessitate automated, scalable infrastructure for reproducible data processing and analysis. Platforms like Nextflow and nf-core have democratized access to primary sequencing analysis through standardized, reproducible bioinformatics pipelines. Specialized bioinformatics cores have become essential in supporting researchers, providing expertise in statistical analysis and interpretation. The Harvard Chan Bioinformatics Core, for example, analyzes numerous projects annually, contributing to publications and offering consultations on experimental design and methodology. While data pre-processing has become more standardized, researchers often struggle with complex study designs and appropriate bioinformatics methods. The bcbio-reports project aims to streamline downstream data analysis by providing report templates for various data types and analyses in a single resource. This infrastructure standardizes downstream multi-omic data analysis, allowing researchers to focus on interpretation and biological understanding. The vision of bcbio emphasizes quantifiability, community development, reproducibility, accessibility, portability, and cutting-edge methodologies. This approach aims to overcome challenges in maintaining complex packages in a rapidly evolving research landscape while ensuring reliable and reproducible results.","tags":[],"title":"Unified, community-developed analysis guidelines and templates for multi-omics data interpretability","type":"talk"},{"authors":["Lorena Pantano"],"categories":null,"content":"","date":1742930100,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1742930100,"objectID":"78f7819fb5efa632f511b31885632ba3","permalink":"http://lpantano.github.io/talk/abrf2025/","publishdate":"2025-03-25T14:15:00-05:00","relpermalink":"/talk/abrf2025/","section":"talk","summary":"As part of the panel discussion 'Managing Data Analyses with Nextflow and nf-core in Bioinformatics Core Facilities,' I presented our current project, bcbio-reports, which streamlines multi-omic data analysis by providing standardized report templates. The project focuses on reproducibility, accessibility, and cutting-edge methodologies to assist researchers with data interpretation.","tags":[],"title":"Lorena Pantano: Unified, community-developed analysis guidelines and templates for multi-omics data interpretability","type":"talk"},{"authors":[],"categories":[],"content":"Today, I encountered a familiar dilemma that seems to pop up whenever a simple task comes my way: should I stick to the tried-and-true methods, or should I embrace automation? This time, it was about subsampling raw sequencing data. In my group, we‚Äôve been doing this for ages: copy-pasting an SBATCH script, loading the necessary modules, tweaking the code, submitting it to the cluster, and then closely monitoring it. It usually gets the job done.\nBut, we‚Äôre living in exciting times! With tools like Nextflow, Seqera, and Seqera AI, I decided to take a leap and harness the power of Seqera AI to create a small Nextflow pipeline for processing fastq files and generating subsampled outputs. Within just 30 minutes, I managed to build a pipeline using the seqtk nfcore/module, complete with test data, and config files that enabled Docker compatibility and execution within our Seqera Workspace. Okay, full disclosure, someone else on the team actually ran the pipeline, what makes this even a better example of accesibility.\nOf course, AI didn‚Äôt do all the work for me; it simply kick-started the process. As someone who knows a thing or two about development, I was able to troubleshoot and refine what the AI initially provided. The pipeline did run, but we hit a snag with jobs failing due to memory constraints. It turned out our output files were pretty hefty, so I delved into the tool‚Äôs parameters and quickly adjusted the necessary config settings. Problem solved!\nThis experience is a testament to how we can speed up analyses without sacrificing reproducibility or accessibility. And thanks to Seqera, pinpointing the memory issue was a breeze. I genuinely believe adopting such tools will lower the barriers to creating small or infrequent projects and ultimately improve our research. So, why not give your own small pipeline a shot?\nAnd yes, this post got a little help from Harvard Open AI GPT-4 to bring it to you.\n","date":1732204800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1732204800,"objectID":"06454b628bdc751e6f496d63b008347e","permalink":"http://lpantano.github.io/post/2024/nextflow_seqera_ai_in_30min/","publishdate":"2024-11-21T12:00:00-04:00","relpermalink":"/post/2024/nextflow_seqera_ai_in_30min/","section":"post","summary":"Example of automation with miniaml investment but good results","tags":[],"title":"Showcase: My Quick Dive into Pipeline Automation with Seqera AI","type":"post"},{"authors":null,"categories":["Visualization"],"content":"Overview An interactive dashboard built with React.js that visualizes personal training data from Apple Health and Garmin Connect apps. This project demonstrates data visualization best practices and the importance of personal data ownership.\nView Live Dashboard ‚Üí\nKey Features Multi-source Data Integration: Combines data from Apple Health and Garmin Connect Interactive Visualizations: Track adaptations in speed, distance, time, and heart rate over time Responsive Design: Built with React.js for a smooth user experience Data Ownership Focus: Demonstrates how individuals can take control of their health data Technical Approach This dashboard emphasizes the importance of:\nPersonal data ownership and management Standardized data export formats Independent data analysis capabilities User empowerment over corporate data silos What It Shows The dashboard tracks my personal training progress, revealing patterns in:\nSpeed improvements over time Distance progression Heart rate adaptation Training consistency Future enhancements will correlate this data with broader health insights to provide a more comprehensive view of fitness and well-being.\nWhy This Matters Too often, our personal health data is locked in proprietary apps or leveraged by large corporations. This project advocates for:\nApps offering data export in standardized formats Individual control over personal data Informed decision-making through accessible analytics Independence from vendor lock-in For more information or to discuss similar visualization projects, feel free to reach out.\n","date":1731196800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1731196800,"objectID":"d3f810beef76a499d7a589261000c9ef","permalink":"http://lpantano.github.io/portfolio/training-dashboard/","publishdate":"2024-11-10T00:00:00Z","relpermalink":"/portfolio/training-dashboard/","section":"portfolio","summary":"Interactive React.js dashboard for personal fitness data visualization and analysis","tags":["Visualization","Fitness data"],"title":"Training Progress Dashboard","type":"portfolio"},{"authors":null,"categories":null,"content":"An interactive dashboard built with React.js that visualizes personal training data from Apple Health and Garmin Connect apps. This project demonstrates data visualization best practices and the importance of personal data ownership.\nView Live Dashboard ‚Üí\nKey Features Multi-source Data Integration: Combines data from Apple Health and Garmin Connect Interactive Visualizations: Track adaptations in speed, distance, time, and heart rate over time Responsive Design: Built with React.js for a smooth user experience Data Ownership Focus: Demonstrates how individuals can take control of their health data Technical Approach This dashboard emphasizes the importance of:\nPersonal data ownership and management Standardized data export formats Independent data analysis capabilities User empowerment over corporate data silos What It Shows The dashboard tracks my personal training progress, revealing patterns in:\nSpeed improvements over time Distance progression Heart rate adaptation Training consistency Future enhancements will correlate this data with broader health insights to provide a more comprehensive view of fitness and well-being.\nWhy This Matters Too often, our personal health data is locked in proprietary apps or leveraged by large corporations. This project advocates for:\nApps offering data export in standardized formats Individual control over personal data Informed decision-making through accessible analytics Independence from vendor lock-in For more information or to discuss similar visualization projects, feel free to reach out.\n","date":1731196800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1731196800,"objectID":"8d50874cc3ad402bfe04051c37862af7","permalink":"http://lpantano.github.io/project/training/","publishdate":"2024-11-10T00:00:00Z","relpermalink":"/project/training/","section":"project","summary":"Interactive dashboard for personal fitness data visualization and analysis","tags":["Health Data","Visualizations"],"title":"Training Progress Dashboard","type":"project"},{"authors":[],"categories":[],"content":"Do you work with Computational Biology/Bioinformatics scientists (CBS)? Do you value their work and relationship? Answer these questions and I will tell you: Have you ever generated data without talking to a CBS and then had a meeting to tell them what you need and what to do? Have you ever met with a CBS to tell them the figure you want or the analysis you wish for without discussing the scientific hypothesis? Have you ever made a timeline or assured delivery of a project that involves analysis of a CBS team without discussing it deeply with them?\nIf you answer YES to any of that, then you are not appreciating Computational Biology scientists (I know it isn‚Äôt what you mean) and you are making your life more difficult. Not only that, but your projects are NOT efficiently executed, and there will be a lot of frustration and delays because of not talking to us first.\nBut it is EASY to change. Next time you think you need to generate any high-throughput data, before even planning the experiment, start meeting with the CBS team. Explain your scientific hypothesis or question, and ask us: Do you know any technology to generate data that will support or not this hypothesis? What are the key aspects we need to think about for the experimental design? What resources do you need? What limitations do you see? Computational biologists are not a Microsoft Office Suite for other fields. We understand the technologies that generate the data we analyze. For instance, there is nothing simple about RNAseq. There are more than 60 steps from your cells to raw data, and there are more than 50 computational methods applied to the data to get you the best gene expression estimation. Protocols get cheaper, shorter and automated, but they are still COMPLEX. The analysis gets faster and cheaper, but they are still COMPLEX. Not because you don‚Äôt see it, it is not there. There is no perfect technology; all of them are approximations, and only the experts who have spent years with them will know how to go from estimation to insights.\nI hope this post saves one project. Just try next time to initiate the effort meeting with the CBS the moment you have the IDEA.\n","date":1723737600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1723737600,"objectID":"dfc3675ee6bdf0395546e714b86cc083","permalink":"http://lpantano.github.io/post/2024/2024-08-perspective1/","publishdate":"2024-08-15T12:00:00-04:00","relpermalink":"/post/2024/2024-08-perspective1/","section":"post","summary":"Talk to a computational biologist scientist from the idea not the data","tags":[],"title":"Perspective: Note directed to leadership in Biology, Translational, Chemistry and Technology.","type":"post"},{"authors":["BaWIB","BWCB"],"categories":null,"content":"","date":1718233200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1718233200,"objectID":"b74aa63a7f8642d422d6b34faf32cc1d","permalink":"http://lpantano.github.io/talk/panel2024wib/","publishdate":"2024-06-12T18:00:00-05:00","relpermalink":"/talk/panel2024wib/","section":"talk","summary":"I had the privilege of participating in a panel discussion with [Boahemaa Adu-Oppong](https://www.linkedin.com/in/badu-oppong/?lipi=urn%3Ali%3Apage%3Ad_flagship3_detail_base%3Bk5qNa3FuRkqWVT6uwAyk4g%3D%3D), PhD (BWCB Member), [Eleanor Howe](https://www.linkedin.com/in/eleanorahowe/?lipi=urn%3Ali%3Apage%3Ad_flagship3_detail_base%3Bk5qNa3FuRkqWVT6uwAyk4g%3D%3D), and [Asha S. Collins](https://www.linkedin.com/in/ashacollins/?lipi=urn%3Ali%3Apage%3Ad_flagship3_detail_base%3Bk5qNa3FuRkqWVT6uwAyk4g%3D%3D). We shared our career journeys, discussed the impact of mentors on our professional lives, and talked about our efforts to mentor others who seek guidance. While all of us have demanding jobs, we also focused on how we balance our careers and our mentoring responsibilities. We offered advice on effectively finding mentors and gaining valuable insights. It was a great experience, and I enjoyed speaking with everyone afterwards. I hope the community continues to expand, and that we achieve equal opportunities at every stage of our careers. See a summary from one of the organizers [Jenea I. Adams](https://www.linkedin.com/in/jeneaadams/) on [linkedin](https://www.linkedin.com/posts/jeneaadams_fogboston-compbio-bioinformatics-activity-7208510528539770880-86Ds?utm_source=share\u0026utm_medium=member_desktop). Know more about these two groups at [Black Women CompBio](https://www.blackwomencompbio.org) and [Boston Area Women in Bioinformatics](https://linktr.ee/bawib).","tags":[],"title":"BaWIB X BWCB joint meetup! Leveraging Mentorship Through Career Hurdles","type":"talk"},{"authors":["Nextflow","Lorena Pantano"],"categories":null,"content":"","date":1716491700,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1716491700,"objectID":"77265c21fac426850e5497a1ce2f06df","permalink":"http://lpantano.github.io/talk/nextflow2024/","publishdate":"2024-05-23T14:15:00-05:00","relpermalink":"/talk/nextflow2024/","section":"talk","summary":"The Harvard Chan Bioinformatics Core is dedicated to fostering collaboration within the Life Sciences, aiming to expedite research endeavors using innovative and proven methodologies for high-throughput sequencing data. In 2011, in response to the absence of a globally adaptable workflow manager at the time, Brad Chapman began developing Bcbio, a Python-based NGS workflow manager, for the Core. Bcbio, which synthesizes insights learned from numerous projects to provide best-practice workflows, gained traction within and beyond the Core and has been embraced by academic researchers, hospitals, and industry alike. Continuously adapting to meet the evolving demands of diverse infrastructure architectures, Bcbio has faced the ongoing challenge of remaining current and adaptable. Over the past five years, the nf-core community has harnessed the capabilities of Nextflow as a workflow manager, fostering the creation of an international, open-source ecosystem supporting over 50 pipelines. As ambassadors of analysis reproducibility and scalability, the Harvard Chan Bioinformatics Core recognizes the imperative of transitioning to nf-core, albeit a complex process in our organization. In this presentation, we outline the rationale behind this migration, elucidate the challenges we are encountering, and delineate our roadmap toward community-wide adoption, drawing upon our experiences with the Bcbio platform.","tags":[],"title":"Lorena Pantano: Transitioning through the nf-core era at the Harvard Chan Bioinformatics Core","type":"talk"},{"authors":[],"categories":[],"content":"And here we go again, after 5 years working in early-stage companies, I decided to share what I learned about building an infrastructure that works for the needs of a small company. Note, that there won‚Äôt be a unique solution to this, and depending on the data input throughput the strategy will change. A good introduction to DataOmics and why this is important can be found at Hammerspace in an interview with Eleanor Howe.\nBefore I start, many other great experts have already talked about this, I learned from them and applied much of what they have said: Michele Busby, and recently from Jack Lindamood.\nNow some context, because context matters. I built everything from scratch at NextRNA. This company focused on targeting lncRNA-protein interactions with small molecules to expand the therapy landscape in oncology and neurodegeneration. The data we use is mainly RNAseq, since we are focusing on detecting lncRNA drivers. We have to internalize raw data from big studies like TCGA and similar, to re-analyze it with our pipeline and annotation.\nAWS cloud services are what is working for us, and it helps us to be stable.\nNetwork: we have two VPCs, with two subnets (private and public). We only use the private subnet and we connect to them through the VPN Client services and with the VPN tunnels to our office. All machines have specific group security configurations to allow only the machine-to-machine communication we know will happen. This can be painful, but it will keep you aware of what is accessible. One VPC is dedicated to shared servers ( I will talk later about this), and another, to machines that will be created through the Batch service, you can call it our HPC space. Storage: we use mainly S3, we have different buckets depending on data usage policies. We store controlled data that needs to follow specific data usage agreements with NIH. We have permanent processed data and raw data with different storage classes to make it more cost-effective. We have an EFS that is mounted on our shared servers, so every temporary data that we need meanwhile we run downstream data analyses can be accessed from different applications. Some of this data is not temporary but is small and need fast access by Web-Apps, so we keep it here instead of S3. Shared Servers: we decided to go with the now-name Posit Bundle: workbench, connect and package manager. This together with our shared file system has made my team collaboration very efficient. About the software, we use all the same R version, with the same R packages. This ensures reproducibility. We decide as a team, the time to update to the next R version and what are the migration steps needed for this. This allows us to publish visualization tools very easily as well, and it has fostered the relationship with the other groups in the company. Nothing gives me more joy than seeing my team talking every day with colleagues from other groups. Pipelines: The biggest contribution to our better efficiency has been using Seqera platform together with NextFlow pipelines. I will always go with this, it makes it so easy to know what is going on, help debug, relaunch pipelines‚Ä¶ And there are features we are not using yet that will make many other processes easier, like datasets ready to be analyzed at any point, visualizing reports, spin-off on-demand machines‚Ä¶ GitHub: this is not new, but I want to share how we use it. We decided on some naming conventions for repositories, have templates repositories, and have documentation in the repository. Have a company internal package that collects all the common code that is used now and then, so we make sure that repetitive analyses of data are the same, and anybody can work on them. As well we have our figure theme so we are consistent when we create reports. We use it a lot for BD material creation. Finally, even if it is not part of the computing infrastructure, I would say managing projects efficiently is important. We tried different things, but what worked the best was Trello. We decided on a protocol on what a card would mean, how to annotate the card, how to see the workload of the team only by looking at the Trello board‚Ä¶and it worked like magic. We have a weekly meeting to align on the short-term goals and long-term goals and plan accordingly.\nOther solutions I know they will be good but I couldn‚Äôt explore more because of time constraints and budget limitations. For instance, Code Ocean. I know about Deep Origin, it would be more like an advanced software as a service but it could be part of the overall infrastructure to accelerate the time between data and decision. Similar companies, like BigOmics helps to analyze data quickly without thinking on the backend. BioBox is working in new products as well, this one focused on graph data representation.\nMore focused on data, I would evaluate TileDB and Databricks when the time is right and the amount of data and integration are a limitation to your process. If you need more help ‚Ä¶","date":1709136000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1709136000,"objectID":"3332f91073dee386d6c644c50e19ab0e","permalink":"http://lpantano.github.io/post/2024/2024-02-learning-infrastructure/","publishdate":"2024-02-28T12:00:00-04:00","relpermalink":"/post/2024/2024-02-learning-infrastructure/","section":"post","summary":"The mistakes and the success of building as fastest as possible the infrastructure","tags":[],"title":"My Learning Experience with Computational Infrastructure in Biotech/Industry","type":"post"},{"authors":[],"categories":[],"content":"It was that time that after 6 months of having the TP holder broken, we decided to make a cute update. It took a couple of months to finish it. Thanks to Thingverse for the model with some tweaks.\n","date":1702137600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1702137600,"objectID":"f074a9a94f51b9b80247c810dd976d37","permalink":"http://lpantano.github.io/post/2023/walle/","publishdate":"2023-12-09T12:00:00-04:00","relpermalink":"/post/2023/walle/","section":"post","summary":"Finally tired of the broken TP holder and how to make a trip to Home Depot a 2 months project.","tags":[],"title":"3D-printer WALL-E toilet paper holder","type":"post"},{"authors":[],"categories":[],"content":"Last year my mom got cancer, multiple myeloma. I didn‚Äôt know anything about this cancer, and I discovered how horrible it is, even if treatment is available, people get misdiagnosed all the time, and there is no cure. I am doing the marathon this year with the Jimmy fund walk event. NextRNA, the company I work for, joined as a team, and it gave me the opportunity to do something and share my story to bring awareness.\nPlease, if you can, add a few $$ to my fund-raising page: http://danafarber.jimmyfund.org/goto/lopantano, and/or share the link with friends. Any amount will impact people like my mom.\nJune 18, 6 miles Chapter 01: September 2022, my mom started with some back pain and started to lose mobility. She stopped doing her normal activity.\nJune 24, 7.5 miles Chapter 02: One month later, doctors only gave her pain medication, all kinds, nothing was working, and she was not able to walk or sit. The health system denied her any kind of imaging to evaluate further.\nJuly 1, 9 miles Chapter 03: November 2022, my mom was getting worse, not able to move at all, and starting to lose short-term memory and not able to maintain a normal conversation. After a lot of push from my dad, they got a referral from primary care to get an MRI in a private clinic. We needed to wait for 1 more week now.\nJuly 8, 10.5 miles Chapter 04: In December 2022, my mom got accepted into the hospital after having results from the MRI that showed some kind of cancer inside the bones. She had broken discs and ribs. In one day we knew it was MM, protein M levels were incredibly high. At this point, she was spending all the time in bed. She was disoriented. I bought a ticket to Spain right away.\nJuly 15, 12 miles Chapter 05: Still in December 2022, I arrived there to see my mom in bed and told me not to touch her too hard because it hurts‚Ä¶my heart broke. It was late, so I went to bed. The next morning I saw my mom standing up, so weak. That weak was all about finding new ways to make her more comfortable. She couldn‚Äôt sit for more than 20 minutes, she could barely eat. It was week two of chemotherapy and nausea was a strong side effect.\nJuly 22, 13.4 miles Chapter 06: Still in December 2022, we were figuring out everything still. In her third week of chemotherapy, she got a strong reaction to the skin. She was red all over the belly. It was scary, and her PCP didn‚Äôt want to give her anything because she didn‚Äôt know what could happen with her treatment. The PCP told us to go to her oncologist. But, and big BUT, the system is not ready to contact your oncologist. Your option is to go to ER and spend 6 hours until somebody decides if they contact the oncologist. I had to go with my dad to the hospital and intercept her oncologist in the corridor. But we didn‚Äôt find him, so we asked a nurse who had some compassion for us and call the oncologist. He told us to come the next day and ask for an appointment during the day. We had to wait 3 hours the next day, with my mom in a wheelchair in pain and taking morphine every 2 hours. It was a reaction to some antibiotic. It took 2 weeks to go away.\nJuly 30, 13 miles Chapter 07: December 25th, After this, we got to just live one day at a time. Christmas came, we celebrate as we could. We had dinner at 7 pm and my mom was in bed at 8 pm as any other day. It was so sad seeing her eat that little. My mom enjoyed cooking and eating, but this year was not like that.\nAugust 12, 9 miles (back from vacation) Chapter 08: December 31st, Nothing else happened that last week of the year. New Year‚Äôs Eve came and we did the same as a normal day. I cooked some traditional empanadas and we were done by 8 pm. She barely could stay sitting for more than 20 minutes. She still needed help getting ready for bed. Amazingly, she could still go upstairs by herself though.\nAugust 19, 12 miles (back on training mode) Chapter 09: January 2023, last week of treatment. The first week of January she started to be able to change clothes by herself. That was nice to see. Gain some independence. We decided to walk for 10 minutes one day, and we repeated the next day. That helped her. It was time for me to come back to Boston. After all this month, at least my mom was moving a little bit more, and treatment seemed to be working. Protein M reduced by 50%.\nSeptember 2, 16 miles (hike in CT) Chapter 10: February 2023, the second cycle went without any surprise. Some skin reactions, but nothing compared to everything she went through in the past months. I tried to call every day, but it was difficult with work and time difference. Still, I could see she could move more. She kept walking 10min a day.\nSeptember 9, 18 miles Chapter 11: May to August 2023. She went through 4 more cycles, a total of 6 at this point. Numbers were going down every time. Although she improved, the pain is still there. Two weeks before I went to visit this past summer, she got a stomach virus that left her in bed again. No strength. They spent 5h in the emergency ‚Ä¶","date":1685635200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1696089600,"objectID":"a9c191416133664c0fab81d80695893a","permalink":"http://lpantano.github.io/post/2023/2023-06-01-raising-for-cancer-research/","publishdate":"2023-06-01T12:00:00-04:00","relpermalink":"/post/2023/2023-06-01-raising-for-cancer-research/","section":"post","summary":"My personal experience with cancer and how much work still to do","tags":[],"title":"My story with cancer - Jimmy fund walk Oct 1st","type":"post"},{"authors":["Bio Talent","Lorena Pantano"],"categories":null,"content":"","date":1631941200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1631941200,"objectID":"6d4416503a91a93c85f23f6e7795a9f8","permalink":"http://lpantano.github.io/talk/biotalent2021/","publishdate":"2021-09-18T00:00:00-05:00","relpermalink":"/talk/biotalent2021/","section":"talk","summary":"With a global push in recent years to encourage young women toward careers in STEM, the life sciences have benefited enormously from more inclusive priorities and populations at the entry-level. Where do we stand as an industry, though, in our advocacy for and support of women progressing upwards, and who does this responsibility sit with?","tags":[],"title":"Women in Life Sciences: How do we Close the Gender Gap in Leadership?","type":"talk"},{"authors":["Nextflow","Rob Lalonde","Lorena Pantano"],"categories":null,"content":"","date":1631682000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1631682000,"objectID":"81ad7dba8890338cb0ed646ff8b3a60d","permalink":"http://lpantano.github.io/talk/nextflow2021/","publishdate":"2021-09-15T00:00:00-05:00","relpermalink":"/talk/nextflow2021/","section":"talk","summary":"In this podcast, Rob Lalonde of Seqera Labs speaks with Lorena Pantano, head of Computational Biology at NextRNA, a firm leading the next revolution in RNA-directed therapeutics located in Cambridge, Massachusetts. In this fascinating discussion, Rob and Lorena talk bioinformatics, life in a startup, and women in technology.","tags":[],"title":"Inside a Bioinformatics Startup ‚Äì with NextRNA Therapeutics","type":"talk"},{"authors":[],"categories":[],"content":"If you came here it is because the twitter wasn‚Äôt enough for you and somehow you are curious about why I moved to industry after so many years in academia. Although I am sure this event has a p-value \u0026gt; 0.05 , then is not significant. (wink wink)\nBut if you know me a little bit, you may be surprised about this change in my career. It was a difficult decision for me, indeed. Somehow, I see this as a no turning back point, maybe is not totally true. I have advocated, so many times, that my reason to stay in academia is that there are more chances to help each other, to create open-source resources, to move forward together‚Ä¶ that somehow, moving to industry is the opposite of all that.\nHowever, academia couldn‚Äôt give me more, and I didn‚Äôt feel I was giving more. I decided a while ago to give up on a tenured career and dedicated many years to work inside a core facility at HSPH. I met awesome people, I learned from the best, I got to work with really amazing data‚Ä¶but there is a price for that. Being mainly an analyst made me see some parts that weren‚Äôt that nice. I realized many researchers will see you as a machine of producing data/figures/tables. They only care about that figure that will show the reviewer they were right. I saw how I couldn‚Äôt get into the project more than for a ‚Äòquick‚Äô analysis of the data, without getting into the biology or the goal of the project.\nNot only that, but I realized I hadn‚Äôt a future, I would be stuck forever in that position, it was a senior position, but I really want to move forward and up. And after my second try at MIT, in another Bioinformatics core, I didn‚Äôt see that coming any time soon.\nIt was time to think about why I am in the science business. Somehow, when I was young, I felt attracted to this world. I forgot about why, but what I liked was to work with people, together, to understand the molecular biology of a system. There was something else, it needed to be something that I believed in.\nAnd this is when eGenesis Bio - Engineering Life came into my sight. The vision is simple: stop people dying because of a lack of compatible organs. The solution is almost science fiction: genome editing on pigs to clone them and use those organs in humans.\nI went to meet them, and I found a wonderful team and a challenging project. It was time to decide, and it was hard. Curiously, the main reasons that were stopping for saying yes, were mainly related to fear. A fear that the system put on me:\nYou need to publish Nature, you need to be known on twitter, to be invited to conferences‚Ä¶ otherwise, you won‚Äôt move forward in your career, you won‚Äôt have a good job. And yes, I don‚Äôt have first-author papers in Nature, I am not famous on twitter, I am not invited to conferences, and leaving academia means I will never be that, for sure. I felt like a failure. Because I didn‚Äôt get any of that, and I will never get it. And somehow, I ended up thinking that was the only way to measure success.\nLuckily me, I read this book I had since months ago: Brave, Not Perfect: Reshma Saujani, and helped me to see that feeling, those thoughts, as something external and not something that was part of me. At this point, I really wanted to forget about all the pressure I had on my shoulders and do just my job, my job on something that I consider relevant, and with the people I want to be.\nSo, of course, I decided to move on. If the only reason why you won‚Äôt make a change is because of fear to fail/change/future, then you should definitely do it. (read the book, seriously)\nIn summary, I got to meet myself again, after so many years doing what the system has told me to do to get a good job, and have a future. I remembered what is my passion, I remembered to believe in myself, and let life to reward my decisions differently (this I will know in a year or so).\nSome other things I did meanwhile I was in this phase:\nWrite my research, teaching and diversity statements and apply for Associate Professors to 5 different positions to 5 different universities. I didn‚Äôt pass any filter. Good mental exercise, yes, I know, 5 positions are nothing, you should apply to 30, or that was the main advice I got. I explored to change totally my career, as a project manager or data scientist in a non-biomedical field. I took some courses, and I didn‚Äôt feel the click that I expect when you are in the right place. I felt miserable and with the lowest self-esteem in my life. I started climbing indoors and working out with a personal trainer. All those negative feelings went away with time. Now I can do 2 pulls-up in a row for the first time in my life at the age of 37. ","date":1570138960,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570138960,"objectID":"ff0e57f6dfdfafdaeee5f05cfa745554","permalink":"http://lpantano.github.io/post/2019/2019-10-03-move-to-egenesis/","publishdate":"2019-10-03T17:42:40-04:00","relpermalink":"/post/2019/2019-10-03-move-to-egenesis/","section":"post","summary":"My personal experience giving up on academia to bet on industry","tags":[],"title":"My transition to biotech","type":"post"},{"authors":["Kathleen Hanlon","Alex Thompson","Lorena Pantano","John N Hutchinson","Arshed Al-Obeidi","Shu Wang","Meghan Bliss-Moreau","Jennifer Helble","Gabriela Alexe","Kimberly Stegmaier","Daniel E Bauer","Ben A Croker"],"categories":null,"content":"","date":1567296000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1567296000,"objectID":"a067175874b4b26b03c272a1cf7b5081","permalink":"http://lpantano.github.io/publication/hanlon-2019/","publishdate":"2019-09-08T18:14:44.067925Z","relpermalink":"/publication/hanlon-2019/","section":"publication","summary":"Genetic modification of human leukemic cell lines using CRISPR-Cas9 has become a staple of gene-function studies. Single-cell cloning of modified cells is frequently used to facilitate studies of gene function. Inherent in this approach is an assumption that the genetic drift, amplified in some cell lines by mutations in DNA replication and repair machinery, as well as non-genetic factors will not introduce significant levels of experimental cellular heterogeneity in clones derived from parental populations. In this study, we characterize the variation in cell death of fifty clonal cell lines generated from human Jurkat and MOLT-4 T-cells edited by CRISPR-Cas9. We demonstrate a wide distribution of sensitivity to chemotherapeutics between non-edited clonal human leukemia T-cell lines, and also following CRISPR-Cas9 editing at the NLRP1 locus, or following transfection with non-targeting sgRNA controls. The cell death sensitivity profile of clonal cell lines was consistent across experiments and failed to revert to the non-clonal parental phenotype. Whole genome sequencing of two clonal cell lines edited by CRISPR-Cas9 revealed unique and shared genetic variants, which had minimal read support in the non-clonal parental population and were not suspected CRISPR-Cas9 off-target effects. These variants included genes related to cell death and drug metabolism. The variation in cell death phenotype of clonal populations of human T-cell lines may be a consequence of T-cell line genetic instability, and to a lesser extent clonal heterogeneity in the parental population or CRISPR-Cas9 off-target effects not predicted by current models. This work highlights the importance of genetic variation between clonal T-cell lines in the design, conduct, and analysis of experiments to investigate gene function after single-cell cloning. Copyright oÃßpyright 2019 Elsevier Inc. All rights reserved.","tags":null,"title":"Single-cell cloning of human T-cell lines reveals clonal variation in cell death responses to chemotherapeutics.","type":"publication"},{"authors":null,"categories":null,"content":" JobID JobName NCPUS MaxRSS AveRSS Elapsed ------------ ------------------------------ ---------- ---------- ---------- ---------- 14150319 index 2 91.06G 0 01:26:32 14153823 kallisto 2 67.28G 65.34G 00:59:35 14156768 bus-correct 4 1.19G 1.19G 00:01:29 14156812 bus-capture-cdna 4 16.16G 10.22G 00:07:59 14156835 bus-capture-intron 4 16.27G 16.27G 00:06:54 ","date":1563494400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1563494400,"objectID":"75f5dc4296f0892f2128ec41fd6aa353","permalink":"http://lpantano.github.io/post/2019/2019-07-19-kallisto-bustools/","publishdate":"2019-07-19T00:00:00Z","relpermalink":"/post/2019/2019-07-19-kallisto-bustools/","section":"post","summary":" JobID JobName NCPUS MaxRSS AveRSS Elapsed ------------ ------------------------------ ---------- ---------- ---------- ---------- 14150319 index 2 91.06G 0 01:26:32 14153823 kallisto 2 67.28G 65.34G 00:59:35 14156768 bus-correct 4 1.19G 1.19G 00:01:29 14156812 bus-capture-cdna 4 16.16G 10.22G 00:07:59 14156835 bus-capture-intron 4 16.27G 16.27G 00:06:54 ","tags":["hpc","singlecell"],"title":"kallisto-bustools","type":"post"},{"authors":null,"categories":null,"content":"I found myself to force to use cellranger. Meanwhile it helps a lot to run from bcl files to single cell counts matrixes, I discovered that is quite difficult to control many options related to optimization.\nI have to run more than 200 samples in a short time of period. In my current position at MIT, I joined the OpenMind cluster in the McGovern institute. I was pleased to find a very flexible cluster, but as any other cluster you need to respect other users.\nMy samples are human samples, so I need a lot of memory so STAR can run. The command line is easy to set up:\ncellranger count --id=SAMPLE --transcriptome=GRCh38_pre_mRNA --fastqs=PATH2FASTQS --sample=SAMPLE\nOf course, that is in local mode. If you want to set up a job to a cluster, it would look like this:\n#!/bin/bash #SBATCH -N 1 #SBATCH -c 6 #SBATCH --mem=12000 #SBATCH -t 0-48:00:00 #SBATCH -J cellr #SBATCH -e job-counts.e #SBATCH -o job-counts.o ## SBATCH --mail-type=END,FAIL # this line is commented ## SBATCH --mail-user=user@mit.edu # this line is commented cellranger count --id=SAMPLE --transcriptome=GRCh38_pre_mRNA \\ --fastqs=PATH2FASTQS --sample=SAMPLE \\ --localcores=6 --localmem=120 The main problem with that is you are using 120G during all the process that could go to 1-2 days.\nI discovered that you can setup the cluster mode to make cellranger to send jobs to the cluster. However, slurm is not a option to the documentation, BUT you can specify a template file:\n#!/bin/bash #SBATCH -J __MRO_JOB_NAME__ #SBATCH -N 1 #SBATCH -c __MRO_THREADS__ #SBATCH --mem=__MRO_MEM_GB__G #SBATCH -o __MRO_STDOUT__ #SBATCH -e __MRO_STDERR__ #SBATCH -t 0-48:00:00 #SBATCH --qos=\u0026#34;normal\u0026#34; __MRO_CMD__ The command would look like this:\ncellranger count --id=SAMPLE --transcriptome=GRCh38_pre_mRNA \\ --fastqs=PATH2FASTQS --sample=SAMPLE \\ --jobmode=slurm.template \\ --maxjobs=3 --jobinterval=1000 I was feeling victory, ha ha ha, BUT I saw that the ALIGN step was requesting 220G of memory‚Ä¶. WHAT!!!!!????? or better WATTT????!!!!!.\nnote: this is set up during genome generation with the parameters:\n--memgb=\u0026lt;num\u0026gt; Maximum memory (GB) used when aligning reads with STAR. Defaults to 16. note: default is 16G but if I use that then my jobs are cancelled because using more memory than requested, as I expected considering STAR needs more than that for human genome.\nI guess I didn‚Äôt look at the first place I should have looked, but it took me some time to discovered that the memory is coming from a file in the reference genome folder:\ncat GRCh38_pre_mRNA/reference.json { \u0026#34;fasta_hash\u0026#34;: \u0026#34;954a9c3916ef1544c9358445440b9683fc061c71\u0026#34;, \u0026#34;genomes\u0026#34;: [ \u0026#34;GRCh38_pre_mRNA\u0026#34; ], \u0026#34;gtf_hash\u0026#34;: \u0026#34;12aae438159b35282adaf643cca4dc5887b0448a\u0026#34;, \u0026#34;input_fasta_files\u0026#34;: [ \u0026#34;Homo_sapiens.GRCh38.dna.toplevel.fa\u0026#34; ], \u0026#34;input_gtf_files\u0026#34;: [ \u0026#34;GRC38_preRNA.gtf\u0026#34; ], \u0026#34;mem_gb\u0026#34;: 220, \u0026#34;mkref_version\u0026#34;: \u0026#34;3.0.2\u0026#34;, \u0026#34;threads\u0026#34;: 24, \u0026#34;version\u0026#34;: null } I realized that when I found, after 100 ls/cat/less/grep, this file with these lines of code:\ncellranger-3.0.2/cellranger-cs/3.0.2/lib/python/cellranger/utils.py def _load_reference_metadata_file(reference_path): reference_metadata_file = os.path.join(reference_path, cr_constants.REFERENCE_METADATA_FILE) with open(reference_metadata_file, \u0026#39;r\u0026#39;) as f: return json.load(f) So, easy peasy, I changed that to 110. I relaunched the job I was using to test, and found that it was still setting up 220G‚Ä¶WHY!?!!? well, it seems if you relaunch in a step where the alignment has already begun, there is a cache for the resources. So after more time trying to figure out this and asking myself, why I decided my career path to be bioinformatics, I tried a fresh start and‚Ä¶IT WORKED.\nHow happy one can be to see a job requesting the expected resources.\nIncredible happy!\nI went a step further, and looked how much memory actually it was using during the alignment step, and I saw that actually only needs 64G, so I updated to 72G, to gain more karma from the HPC world.\nThere is one more thing, that will set jobs of 72G and 4 cores, if you want to increase the number of cores, then use this option --mempercore 6 or whatever number that you want: mempercore = 72G/final_cores.\nWorkflow Finally, I felt that I was doing my best to behave and avoid making angry other people using the hpc. The final setup looks like this:\nmeta-script to send all the samples to a master job: runner.sh. It accepts a file where first column is sample name and second column is fastq_path set -o pipefail # trace ERR through pipes set -o errtrace # trace ERR through \u0026#39;time command\u0026#39; and other functions set -o nounset ## set -u : exit the script if you try to use an uninitialised variable set -o errexit ## set -e : exit the script if any statement returns a non-true return value # set -v # you can uncomment all these lines to have a better debugging # set -x # export PS4=\u0026#39;+(${BASH_SOURCE}:${LINENO}): ${FUNCNAME[0]:+${FUNCNAME[0]}(): }\u0026#39; while IFS=\u0026#34; \u0026#34; read -r sample paths do RUN=0 if [[ ! -e $sample/filtered_feature_bc_matrix.h5 ]]; then RUN=1 # run if ‚Ä¶","date":1562803200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1562803200,"objectID":"cb81eb0ae3045bf6d204eb18a2449267","permalink":"http://lpantano.github.io/post/2019/2019-07-12-cellranger-efficiency-in-hpc-copy/","publishdate":"2019-07-11T00:00:00Z","relpermalink":"/post/2019/2019-07-12-cellranger-efficiency-in-hpc-copy/","section":"post","summary":"I found myself to force to use cellranger. Meanwhile it helps a lot to run from bcl files to single cell counts matrixes, I discovered that is quite difficult to control many options related to optimization.\n","tags":["hpc","singlecell"],"title":"How to set up cellranger to make your hpc admin happy","type":"post"},{"authors":["William C Engeland","Logan Massman","Lauren Miller","Sining Leng","Emanuele Pignatti","Lorena Pantano","Diana L Carlone","Paulo Kofuji","David T Breault"],"categories":null,"content":"","date":1561939200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1561939200,"objectID":"8a0b56c6994f594777fa5e0d326d767e","permalink":"http://lpantano.github.io/publication/engeland-2019/","publishdate":"2019-09-08T18:14:44.069568Z","relpermalink":"/publication/engeland-2019/","section":"publication","summary":"The circadian glucocorticoid (GC) rhythm is dependent on a molecular clock in the suprachiasmatic nucleus (SCN) and an adrenal clock that is synchronized by the SCN. To determine whether the adrenal clock modulates GC responses to stress, experiments used female and male Cyp11A1Cre/+:: Bmal1Fl/Fl KO (SCC-KO) mice, in which the core clock gene, Bmal1, is deleted in all steroidogenic tissues including the adrenal cortex. Following restraint stress, female and male SCC-KO mice demonstrate augmented plasma corticosterone, but not plasma ACTH. In contrast, following submaximal scruff stress, plasma corticosterone was elevated only in female SCC-KO mice. Adrenal sensitivity to ACTH was measured in vitro using acutely dispersed adrenocortical cells. Maximal corticosterone responses to ACTH were elevated in cells from female KO mice without affecting the EC50 response. Neither the maximum nor the EC50 response to ACTH was affected in male cells, indicating that female SCC-KO show a stronger adrenal phenotype. Parallel experiments were done using female Cyp11B2 (Aldosterone Synthase)Cre/+:: Bmal1Fl/Fl mice, adrenal cortex-specific Bmal1 null (Ad-KO) mice. Plasma corticosterone was increased in Ad-KO mice following restraint or scruff stress, and in vitro responses to ACTH were elevated in adrenal cells from Ad-KO mice, replicating data from female SCC-KO mice. Gene analysis showed increased expression of adrenal genes in female SCC-KO mice involved in cell cycle control, cell adhesion-extracellular matrix interaction and ligand receptor activity that could promote steroid production. These observations underscore a role for adrenal Bmal1 as an attenuator of steroid secretion that is most prominent in female mice. Copyright oÃßpyright 2019 Endocrine Society.","tags":null,"title":"Sex Differences in Adrenal Bmal1 Deletion-Induced Augmentation of Glucocorticoid Responses to Stress and ACTH in Mice.","type":"publication"},{"authors":["Joan Pallar√®s-Albanell","M Teresa Zome√±o-Abell√°n","Georgia Escaram√≠s","Lorena Pantano","Aroa Soriano","Miguel F Segura","Eul√†lia Mart√≠"],"categories":null,"content":"","date":1559347200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1559347200,"objectID":"c74ead81373f736353a7c9086f4a0846","permalink":"http://lpantano.github.io/publication/pallarsalbanell-2019/","publishdate":"2019-09-08T18:14:44.070453Z","relpermalink":"/publication/pallarsalbanell-2019/","section":"publication","summary":"Small non-coding RNAs (sncRNAs), including microRNAs (miRNAs) are important post-transcriptional gene expression regulators relevant in physiological and pathological processes. Here, we combined a high-throughput functional screening (HTFS) platform with a library of antisense oligonucleotides (ASOs) to systematically identify sncRNAs that affect neuronal cell survival in basal conditions and in response to oxidative stress (OS), a major hallmark in neurodegenerative diseases. We considered hits commonly detected by two statistical methods in three biological replicates. Forty-seven ASOs targeting miRNAs (miRNA-ASOs) consistently decreased cell viability under basal conditions. A total of 60 miRNA-ASOs worsened cell viability impairment mediated by OS, with 36.6% commonly affecting cell viability under basal conditions. In addition, 40 miRNA-ASOs significantly protected neuronal cells from OS. In agreement with cell viability impairment, damaging miRNA-ASOs specifically induced increased free radical biogenesis. miRNAs targeted by the detrimental ASOs are enriched in the fraction of miRNAs downregulated by OS, suggesting that the miRNA expression pattern after OS contributes to neuronal damage. The present HTFS highlighted potentially druggable sncRNAs. However, future studies are needed to define the pathways by which the identified ASOs regulate cell survival and OS response and to explore the potential of translating the current findings into clinical applications. Copyright oÃßpyright 2019 The Authors. Published by Elsevier Inc. All rights reserved.","tags":null,"title":"A High-Throughput Screening Identifies MicroRNA Inhibitors That Influence Neuronal Maintenance and/or Response to Oxidative Stress.","type":"publication"},{"authors":["Mira Pavkovic","Lorena Pantano","Cory V Gerlach","Sergine Brutus","Sarah A Boswell","Robert A Everley","Jagesh V Shah","Shannan H Sui","Vishal S Vaidya"],"categories":null,"content":"","date":1559347200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1559347200,"objectID":"19fe5dbf51b9ed7197dfe478573ceaa5","permalink":"http://lpantano.github.io/publication/pavkovic-2019/","publishdate":"2019-09-08T18:15:28.600441Z","relpermalink":"/publication/pavkovic-2019/","section":"publication","summary":"Kidney fibrosis represents an urgent unmet clinical need due to the lack of effective therapies and an inadequate understanding of the molecular pathogenesis. We have generated a comprehensive and combined multi-omics dataset (proteomics, mRNA and small RNA transcriptomics) of fibrotic kidneys that is searchable through a user-friendly web application: http://hbcreports.med.harvard.edu/fmm/ . Two commonly used mouse models were utilized: a reversible chemical-induced injury model (folic acid (FA) induced nephropathy) and an irreversible surgically-induced fibrosis model (unilateral ureteral obstruction (UUO)). mRNA and small RNA sequencing, as well as 10-plex tandem mass tag (TMT) proteomics were performed with kidney samples from different time points over the course of fibrosis development. The bioinformatics workflow used to process, technically validate, and combine the single omics data will be described. In summary, we present temporal multi-omics data from fibrotic mouse kidneys that are accessible through an interrogation tool (Mouse Kidney Fibromics browser) to provide a searchable transcriptome and proteome for kidney fibrosis researchers.","tags":null,"title":"Multi omics analysis of fibrotic kidneys in two mouse models.","type":"publication"},{"authors":null,"categories":null,"content":"We use bcbio-nextgen for the analysis of sequencing data, mainly, (sc)RNAseq, smallRNAseq, DNASeq and ChIPSeq. It is not rare that we get collaborators who wants to re-analyze public data-set.\nInside bcbio, we have bcbio_prepare_samples.py to help to merge multiple files that belong to the same sample into one file to make easier the configuration of bcbio. We extended this script to pull down data from GEO and SRA repository.\nIf you have bcbio. installed, you can create a example.csv file like this:\nsamplenames,description GSM3508215,HEK293T SRR8311268,Hela And then run:\nbcbio_prepare_samples.py --csv example.csv --out fastq This will download and create all the files inside fastq folder. If the samples is paired-end, it will generated the two associated files: R1 and R2.\nCool options to use:\n--remove-source: if you want to keep only final files. you can use full FTP addresses as well under samplenames column NextFlow accepts these SRA ids as well, take a look.\nAnd sra-explorer from Phil Ewels will create a bash script to download the FASTQ files and It has a great search engine where you can use any of these terms to find your public data: GSE30567, SRP043510, PRJEB8073, ERP009109 or human liver miRNA.\nThe only advantage of bcbio is that in the case of multiple files associated to the same sample, it will merge the files together. For instance, if you search in sra-explorer for this\nterm: GSM2598386, you see that multiple files. bcbio. will merge all of them into one and you can run your pipeline directly afterwards. And pretty convenient if you use any of the bcbio pipelines :).\nEnjoy!\n‚Äúhappiness in bioinformatics: when your collaborators give you a CSV file with all the metadata for your raw data and they match.\n","date":1554473582,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1554473582,"objectID":"b0e160464b32292429eb7fa67a7bcc12","permalink":"http://lpantano.github.io/post/2019/2019-04-05-how-to-setup-remote-samples-with-bcbio/","publishdate":"2019-04-05T10:13:02-04:00","relpermalink":"/post/2019/2019-04-05-how-to-setup-remote-samples-with-bcbio/","section":"post","summary":"We use bcbio-nextgen for the analysis of sequencing data, mainly, (sc)RNAseq, smallRNAseq, DNASeq and ChIPSeq. It is not rare that we get collaborators who wants to re-analyze public data-set.\nInside bcbio, we have bcbio_prepare_samples.py to help to merge multiple files that belong to the same sample into one file to make easier the configuration of bcbio. We extended this script to pull down data from GEO and SRA repository.\n","tags":["bcbio","public-data"],"title":"How to set up public dataset analysis with bcbio-nextgen","type":"post"},{"authors":["miRTOP group","Lorena Pantano"],"categories":null,"content":"","date":1549688400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1549688400,"objectID":"c8b33d24e8a5c6a742f1a16d1af5ff4b","permalink":"http://lpantano.github.io/talk/bioclub2019/","publishdate":"2019-02-09T00:00:00-05:00","relpermalink":"/talk/bioclub2019/","section":"talk","summary":"Advances in high-throughput sequencing technologies led to the discovery of isomiRs, which are miRNA sequence variants. In the last year, a few papers have pointed the lack of accuracy of miRNA abundance detection by sequencing technologies. Here, we extend the research to the accuracy of isomiRs detection and quantification by the same technologies. This is an ongoing project of the miRTOP group: https://github.com/miRTop/incubator/tree/master/projects","tags":[],"title":"miRNA variants (isomiRs): real molecules or sequencing artifacts?","type":"talk"},{"authors":["Carla Giner-Delgado","Sergi Villatoro","Jon Lerga-Jaso","Magdalena Gay√†-Vidal","Meritxell Oliva","David Castellano","Lorena Pantano","B√°rbara D Bitarello","David Izquierdo","Isaac Noguera"," others"],"categories":null,"content":"","date":1546300800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1546300800,"objectID":"dcebf9cc6e3df67bbedeb906a1c14192","permalink":"http://lpantano.github.io/publication/giner-2019-evolutionary/","publishdate":"2019-11-03T22:07:36.973137Z","relpermalink":"/publication/giner-2019-evolutionary/","section":"publication","summary":"","tags":null,"title":"Evolutionary and functional impact of common polymorphic inversions in the human genome","type":"publication"},{"authors":["Maria Mavrikaki","Lorena Pantano","David N Potter","Maximilian Aaron Rogers-Grazado","Eleni Anastasiadou","Sami Amr","Frank John Slack","Kerry J Ressler","Nikolaos P Daskalakis","Elena Chartoff"],"categories":null,"content":"","date":1546300800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1546300800,"objectID":"a1c6bfc2b04d07efe735b80debfbd3f7","permalink":"http://lpantano.github.io/publication/mavrikaki-2019-sex/","publishdate":"2019-11-03T22:07:36.971614Z","relpermalink":"/publication/mavrikaki-2019-sex/","section":"publication","summary":"","tags":null,"title":"Sex-dependent changes in miRNA expression in the bed nucleus of the stria terminalis following stress","type":"publication"},{"authors":["miRTOP group","Lorena Pantano"],"categories":null,"content":"","date":1543781172,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1543781172,"objectID":"d30218cb970d8bbeeb56f71126742ac1","permalink":"http://lpantano.github.io/talk/big2018/","publishdate":"2018-12-02T15:06:12-05:00","relpermalink":"/talk/big2018/","section":"talk","summary":"MicroRNAs (miRNAs) are small RNA molecules (~22 nucleotide long) involved in post-transcriptional gene regulation. Advances in high-throughput sequencing technologies led to the discovery of isomiRs, which are miRNA sequence variants. In the last year, a few papers have pointed the lack of accuracy of miRNA abundance detection by sequencing technologies. Here, we extend the research to the accuracy of isomiRs detection and quantification by the same technologies. This is an ongoing project of the miRTOP group: https://github.com/miRTop/incubator/tree/master/projects","tags":[],"title":"MiRNA Wars: The isomiRs menance","type":"talk"},{"authors":["Thomas Desvignes","Phillipe Loher","Karen Eilbeck","Jeffery Ma","Gianvito Urgese","Bastian Fromm","Jason Sydes","Ernesto Aparicio-Puerta","Victor Barrera","Roderic Espin","Eric Londin","Aristeidis G Telonis","Elisa Ficarra","Marc R Friedlander","John H Postlethwait","Isidore Rigoutsos","Michael Hackenberg","Ioannis S Vlachos","Marc K. Halushka","Lorena Pantano"],"categories":null,"content":"","date":1543622400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1543622400,"objectID":"41ced793253aa05b23c919e5434778ee","permalink":"http://lpantano.github.io/publication/desvignes-2018/","publishdate":"2019-09-08T18:15:28.602092Z","relpermalink":"/publication/desvignes-2018/","section":"publication","summary":"Background: MicroRNAs (miRNAs) are small RNA molecules (ÃÉ22 nucleotide long) involved in post-transcriptional gene regulation. Advances in high-throughput sequencing technologies led to the discovery of isomiRs, which are miRNA sequence variants. While many miRNA-seq analysis tools exist, a lack of consensus on miRNA/isomiR analyses exists, and the resulting diversity of output formats hinders accurate comparisons between tools and precludes data sharing and the development of common downstream analysis methods. Findings: To overcome this situation, we present here a community-based project, miRTOP (miRNA Transcriptomic Open Project) working towards the optimization of miRNA analyses. The aim of miRTOP is to promote the development of downstream analysis tools that are compatible with any existing detection and quantification tool. Based on the existing GFF3 format, we first created a new standard format, mirGFF3, for the output of miRNA/isomiR detection and quantification results from small RNA-seq data. Additionally, we developed a command line Python tool, mirtop, to manage the mirGFF3 format. Currently, mirtop can convert into mirGFF3 the outputs of commonly used pipelines, such as seqbuster, miRge2.0, isomiR-SEA, sRNAbench, and Prost!, as well as BAM files. Its open architecture enables any tool or pipeline to output results in mirGFF3. Conclusions: Collectively a comprehensive isomiR categorization system, along with the accompanying mirGFF3 and mirtop API provide a complete solution for the standardization of miRNA and isomiR analysis, enabling data sharing, reporting, comparative analyses, and benchmarking, while promoting the development of common miRNA methods focusing on downstream steps to miRNA detection, annotation, and quantification.","tags":null,"title":"Unification of miRNA and isomiR research: the mirGFF3 format and the mirtop API","type":"publication"},{"authors":null,"categories":null,"content":"This post will show how to configure quickly the colors for the annotation of rows/columns that go on top or on the side of a heatmap.\nI normally use pheatmap a lot. Recently I discovered ComplexHeatmap. In both cases I spend always sometime changing the colors of the annotations. I ended up coding a function inside my package DEGreport to do that.\nGiven a data.frame with metadata data information will do:\nwhite-black scale for numerical variables blue-orange for categorical values with only two categories Set2 palette for categorical values with more than two categories All three color sets can be changed using the parameters function.\nlibrary(DEGreport) library(stemHypoxia) data(stemHypoxia) I am going to use this stemcell experiment dataset I found randomly in Bioconductor page.\nexp = as.matrix(M[,3:30]) rownames(exp) = M[,2] rownames(design) = colnames(exp) design = design[,c(1:2)] design$time = as.factor(design$time) I‚Äôll find the most variable genes.\nmost_variable = names(tail(sort(apply(exp, 1, sd)), 1000)) design$mean_gene = colMeans(exp[most_variable,]) And we can plot the heatmap with new colors with need to specify each variable at a time.\nlibrary(pheatmap) pheatmap(exp[most_variable,], scale = \u0026#34;row\u0026#34;, show_rownames = FALSE, annotation_col = design, annotation_colors = degColors(design)) If you use ComplexHeatmap you can activate col_fun = TRUE to get it working.\nR Session devtools::session_info() ## Warning: \u0026#39;DESCRIPTION\u0026#39; file has an \u0026#39;Encoding\u0026#39; field and re-encoding is not ## possible ## Session info ------------------------------------------------------------- ## setting value ## version R version 3.5.1 (2018-07-02) ## system x86_64, darwin15.6.0 ## ui X11 ## language (EN) ## collate en_US.UTF-8 ## tz America/New_York ## date 2018-09-21 ## Packages ----------------------------------------------------------------- ## package * version date source ## acepack 1.4.1 2016-10-29 cran (@1.4.1) ## annotate 1.58.0 2018-05-01 cran (@1.58.0) ## AnnotationDbi 1.42.1 2018-05-08 Bioconductor ## assertthat 0.2.0 2017-04-11 CRAN (R 3.5.0) ## backports 1.1.2 2017-12-13 CRAN (R 3.5.0) ## base * 3.5.1 2018-07-05 local ## base64enc 0.1-3 2015-07-28 CRAN (R 3.5.0) ## bindr 0.1.1 2018-03-13 CRAN (R 3.5.0) ## bindrcpp 0.2.2 2018-03-29 CRAN (R 3.5.0) ## Biobase 2.40.0 2018-05-01 Bioconductor ## BiocGenerics 0.26.0 2018-05-01 Bioconductor ## BiocParallel 1.14.2 2018-07-08 cran (@1.14.2) ## bit 1.1-14 2018-05-29 CRAN (R 3.5.0) ## bit64 0.9-7 2017-05-08 CRAN (R 3.5.0) ## bitops 1.0-6 2013-08-17 cran (@1.0-6) ## blob 1.1.1 2018-03-25 CRAN (R 3.5.0) ## broom 0.5.0 2018-07-17 CRAN (R 3.5.0) ## checkmate 1.8.5 2017-10-24 cran (@1.8.5) ## circlize 0.4.4 2018-06-10 cran (@0.4.4) ## cluster 2.0.7-1 2018-04-13 CRAN (R 3.5.1) ## colorspace 1.3-2 2016-12-14 CRAN (R 3.5.0) ## compiler 3.5.1 2018-07-05 local ## ComplexHeatmap 1.18.1 2018-06-19 cran (@1.18.1) ## ConsensusClusterPlus 1.44.0 2018-05-01 cran (@1.44.0) ## cowplot 0.9.3 2018-07-15 cran (@0.9.3) ## crayon 1.3.4 2017-09-16 CRAN (R 3.5.0) ## data.table 1.11.4 2018-05-27 cran (@1.11.4) ## datasets * 3.5.1 2018-07-05 local ## DBI 1.0.0 2018-05-02 CRAN (R 3.5.0) ## DEGreport * 1.17.5 2018-09-04 local (lpantano/DEGreport@NA) ## DelayedArray 0.6.5 2018-08-15 cran (@0.6.5) ## DESeq2 1.20.0 2018-05-01 Bioconductor ## devtools 1.13.6 2018-06-27 CRAN (R 3.5.0) ## digest 0.6.16 2018-08-22 CRAN (R 3.5.0) ## dplyr 0.7.6 2018-06-29 CRAN (R 3.5.1) ## edgeR 3.22.3 2018-06-21 cran (@3.22.3) ## evaluate 0.11 2018-07-17 CRAN (R 3.5.0) ## foreign 0.8-71 2018-07-20 CRAN (R 3.5.0) ## Formula 1.2-3 2018-05-03 cran (@1.2-3) ## genefilter 1.62.0 2018-05-01 cran (@1.62.0) ## geneplotter 1.58.0 2018-05-01 cran (@1.58.0) ## GenomeInfoDb 1.16.0 2018-05-01 cran (@1.16.0) ## GenomeInfoDbData 1.1.0 2018-08-31 Bioconductor ## GenomicRanges 1.32.6 2018-07-20 cran (@1.32.6) ## GetoptLong 0.1.7 2018-06-10 cran (@0.1.7) ## ggdendro 0.1-20 2016-04-27 cran (@0.1-20) ## ggplot2 3.0.0 2018-07-03 CRAN (R 3.5.0) ## ggrepel 0.8.0 2018-05-09 cran (@0.8.0) ## GlobalOptions 0.1.0 2018-06-09 cran (@0.1.0) ## glue 1.3.0 2018-07-17 CRAN (R 3.5.0) ## graphics * 3.5.1 2018-07-05 local ## grDevices * 3.5.1 2018-07-05 local ## grid 3.5.1 2018-07-05 local ## gridExtra 2.3 2017-09-09 cran (@2.3) ## gtable 0.2.0 2016-02-26 CRAN (R 3.5.0) ## Hmisc 4.1-1 2018-01-03 cran (@4.1-1) ## htmlTable 1.12 2018-05-26 cran (@1.12) ## htmltools 0.3.6 2017-04-28 CRAN (R 3.5.0) ## htmlwidgets 1.2 2018-04-19 cran (@1.2) ## IRanges 2.14.11 2018-08-24 Bioconductor ## knitr 1.20 2018-02-20 CRAN (R 3.5.0) ## lasso2 1.2-19 2014-05-31 cran (@1.2-19) ## lattice 0.20-35 2017-03-25 CRAN (R 3.5.1) ## latticeExtra 0.6-28 2016-02-09 cran (@0.6-28) ## lazyeval 0.2.1 2017-10-29 CRAN (R 3.5.0) ## limma 3.36.3 2018-08-25 cran (@3.36.3) ## locfit 1.5-9.1 2013-04-20 cran (@1.5-9.1) ## logging 0.7-103 2013-04-12 cran (@0.7-103) ## magrittr 1.5 2014-11-22 CRAN (R 3.5.0) ## MASS 7.3-50 2018-04-30 CRAN (R 3.5.1) ## Matrix 1.2-14 2018-04-13 CRAN (R 3.5.1) ## matrixStats ‚Ä¶","date":1537539182,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1537539182,"objectID":"ed67cfa9a294cad2debea0b0eb91b83f","permalink":"http://lpantano.github.io/post/legacy/2018-09-21-colors-for-annotations-for-heatmaps/","publishdate":"2018-09-21T10:13:02-04:00","relpermalink":"/post/legacy/2018-09-21-colors-for-annotations-for-heatmaps/","section":"post","summary":"This post will show how to configure quickly the colors for the annotation of rows/columns that go on top or on the side of a heatmap.\nI normally use pheatmap a lot. Recently I discovered ComplexHeatmap. In both cases I spend always sometime changing the colors of the annotations. I ended up coding a function inside my package DEGreport to do that.\n","tags":["R","Visualization"],"title":"Get colors for your heatmap annotation","type":"post"},{"authors":null,"categories":null,"content":"This post should show you an easy way to get the following data type integrated into a figure:\nfunctional enrichment analysis gene expression data from any technology miRNA expression data from any technology I am using the function isoNetwork from the package isomiRs, that of course is developed by me :) My ego is not that big, it is just I wanted a figure showing that information, and I couldn‚Äôt find any at a time, but if you know any, tweet me about it to @lopantano.\nThis function needs some pre-computed information, like the normalized expression and the targeted genes by miRNAs. Normally, the significant genes and miRNAs from a differentially expression analysis would do it.\nThe first requirement is two have these two datasets into a SummarizedExperiment object As an example, I am using the published data from Folic Acid Mouse model (GSE65267) that has been analyzed with bcbio-nextgen pipeline and bcbioRNASeq package.\nI saved these analysis into an R object that contains:\nfa_mrna: gene expression fa_mirna: miRNA expression fa_cold: metadata From that, I ran DESeq2 to get the significant genes and miRNAs from the comparison day14 vs day0 (normal).\nR\u0026gt; load(\u0026#34;fa_isonetwork.rda\u0026#34;) R\u0026gt; library(isomiRs) R\u0026gt; library(DESeq2) R\u0026gt; library(SummarizedExperiment) R\u0026gt; R\u0026gt; mi_cold = fa_cold[colnames(fa_mirna), , drop = F] R\u0026gt; mi_dse = DESeqDataSetFromMatrix(round(2^fa_mirna), mi_cold, design = ~day) R\u0026gt; mi_dse = DESeq(mi_dse) R\u0026gt; mi_res = results(mi_dse, name = \u0026#34;day_day14_vs_normal\u0026#34;) R\u0026gt; mi_res = mi_res[!is.na(mi_res$padj), ] R\u0026gt; mi_top = row.names(mi_res[mi_res$padj \u0026lt; 0.05, ]) R\u0026gt; mi_rse = SummarizedExperiment(assays = SimpleList(norm = fa_mirna), colData = mi_cold, + metadata = list(sign = mi_top)) R\u0026gt; R\u0026gt; m_cold = fa_cold[colnames(fa_mrna), , drop = F] R\u0026gt; m_dse = DESeqDataSetFromMatrix(round(2^fa_mrna), m_cold, design = ~day) R\u0026gt; m_dse = DESeq(m_dse) R\u0026gt; m_res = results(m_dse, name = \u0026#34;day_day14_vs_normal\u0026#34;) R\u0026gt; m_res = m_res[!is.na(m_res$padj), ] R\u0026gt; m_top = row.names(m_res[m_res$padj \u0026lt; 0.05, ]) R\u0026gt; m_rse = SummarizedExperiment(assays = SimpleList(norm = fa_mrna), colData = m_cold, + metadata = list(sign = m_top)) After that, I ran the functional analysis with clusterProfiler Bioc package:\nR\u0026gt; library(org.Mm.eg.db) R\u0026gt; library(clusterProfiler) R\u0026gt; R\u0026gt; R\u0026gt; ego \u0026lt;- enrichGO(m_top, org.Mm.eg.db, \u0026#34;ENSEMBL\u0026#34;, ont = \u0026#34;MF\u0026#34;, universe = rownames(m_res)) Actually, it could be anything as far as the table have the same naming that the one coming from this package.\nLast step before the real integration analysis, is to get the predicted targets of the miRNA. This can be done with any package as far as you get a table with two columns: gene and mirna.\nI used two options, one using the already implemented code in the package (that uses targetscan database):\nR\u0026gt; library(targetscan.Mm.eg.db) R\u0026gt; m2t = mirna2targetscan(mi_top, species = \u0026#34;mmu\u0026#34;, org = org.Mm.eg.db, keytype = \u0026#34;ENSEMBL\u0026#34;) R\u0026gt; R\u0026gt; mirna_targets = findTargets(mi_rse, m_rse, m2t[, c(\u0026#34;ENSEMBL\u0026#34;, \u0026#34;mir\u0026#34;)], summarize = \u0026#34;day\u0026#34;, + min_cor = -0.7) ## Dimmension of cor matrix: 49 5233 or using the function get_multimir implemented on multiMiR Bioc package.\nR\u0026gt; library(multiMiR) R\u0026gt; multimir_results \u0026lt;- get_multimir(org = \u0026#34;mmu\u0026#34;, mirna = mi_top, table = \u0026#34;validated\u0026#34;, + summary = TRUE) R\u0026gt; R\u0026gt; library(magrittr) R\u0026gt; m2t_multimir = slot(multimir_results, \u0026#34;data\u0026#34;)[, c(\u0026#34;target_ensembl\u0026#34;, \u0026#34;mature_mirna_id\u0026#34;)] %\u0026gt;% + dplyr::filter(target_ensembl != \u0026#34;\u0026#34;) %\u0026gt;% dplyr::distinct() R\u0026gt; R\u0026gt; mirna_targets = findTargets(mi_rse, m_rse, m2t_multimir, summarize = \u0026#34;day\u0026#34;, + min_cor = -0.7) In both cases, I ran findTargets to use the expression data to make sure the correlation between the miRNA and predicted gene is negative since is the known biological function of miRNAs, being negative modulators.\nFinally, we use isoNetwork to put all the data together, and isoPlotNet to create the final figure with all information.\nR\u0026gt; data \u0026lt;- isoNetwork(mi_rse, m_rse, min_fc = 0.1, summarize = \u0026#34;day\u0026#34;, target = mirna_targets, + enrich = ego) ## Dimmension of cor matrix: 49 305 R\u0026gt; isoPlotNet(data, minGenes = 1) It is an easy way to spot what pathways contain genes that are targeted by miRNAs.\nNote that this function won‚Äôt indicate if a pathway is enriched on miRNA targets. It shows how these three different data set can be put together to explore the relationship among them.\n‚Äúself-control in bioinformatics: be nice to your collaborator when they can not open a TSV file with excel.‚Äù\n","date":1534078800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1534078800,"objectID":"b033be1078cdeb749982f04ee684c2a5","permalink":"http://lpantano.github.io/post/legacy/2018-08-13-omic-figure-for-mirna-gene-functional-data/","publishdate":"2018-08-12T09:00:00-04:00","relpermalink":"/post/legacy/2018-08-13-omic-figure-for-mirna-gene-functional-data/","section":"post","summary":"This post should show you an easy way to get the following data type integrated into a figure:\nfunctional enrichment analysis gene expression data from any technology miRNA expression data from any technology I am using the function isoNetwork from the package isomiRs, that of course is developed by me :) My ego is not that big, it is just I wanted a figure showing that information, and I couldn‚Äôt find any at a time, but if you know any, tweet me about it to @lopantano.\n","tags":["R","miRNA","networks"],"title":"How to plot miRNA, gene expression and functional analysis together","type":"post"},{"authors":["Matthew L. Steinhauser","Benjamin A. Olenchock","John O'Keefe","Mingyue Lun","Kerry A. Pierce","Hang Lee","Lorena Pantano","Anne Klibanski","Gerald I. Shulman","Clary B. Clish","Pouneh K. Fazeli"],"categories":null,"content":"","date":1533081600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1533081600,"objectID":"5cb03e59d6fff71662208fd102a5f9b6","permalink":"http://lpantano.github.io/publication/steinhauser-2018/","publishdate":"2019-09-08T18:15:28.603002Z","relpermalink":"/publication/steinhauser-2018/","section":"publication","summary":"The human adaptive starvation response allows for survival during long-term caloric deprivation. Whether the physiology of starvation is adaptive or maladaptive is context dependent: activation of pathways by caloric restriction may promote longevity, yet in the context of caloric excess, the same pathways may contribute to obesity. Here, we performed plasma metabolite profiling of longitudinally collected samples during a 10-day, 0-calorie fast in humans. We identify classical milestones in adaptive starvation, including the early consumption of gluconeogenic amino acids and the subsequent surge in plasma nonesterified fatty acids that marks the shift from carbohydrate to lipid metabolism, and demonstrate findings, including (a) the preferential release of unsaturated fatty acids and an associated shift in plasma lipid species with high degrees of unsaturation and (b) evidence that acute, starvation-mediated hypoleptinemia may be a driver of the transition from glucose to lipid metabolism in humans.","tags":["Carbohydrate metabolism","Endocrinology","Fatty acid oxidation","Leptin","Metabolism","selected"],"title":"The circulating metabolome of human starvation","type":"publication"},{"authors":["Thomas Desvignes","Karen EIlbeck","Ioannis S. Vlachos","Bastian Fromm","Yin Lu","Marc K. Halushka","Michael Hackenberg","Gianvito Urgese","Elisa Ficarra","Shruthi Bandyadka","Jason Sydes","Peter Batzel","John H. Postlethwait","Phillipe Loher","Eric Londin","Aristeidis G. Telonis","Isidore Rigoutsos","Lorena Pantano"],"categories":null,"content":"","date":1530137582,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1530137582,"objectID":"480f9ff8a07d42275f1a8809e4142a8e","permalink":"http://lpantano.github.io/talk/bosc2018/","publishdate":"2018-06-27T13:13:02-09:00","relpermalink":"/talk/bosc2018/","section":"talk","summary":"MicroRNAs (miRNAs) are small RNA molecules (20-27 nt long) that are involved in eukaryotic  gene regulation. They regulate targeted genes by RNA complementarity, generally between the miRNA seed region and the 3‚Äô UTR of messenger RNAs. They have become relevant to the study of developmental stages and diseases. With the advance of sequencing technology, the cost of detecting the miRNA transcriptome has decreased substantially, and has led to the discovery of isomiRs (with slight sequence variations relative to the annotated miRNAs). As a consequence, the amount of miRNA data has increased exponentially in the last 5 years, together with the number of pipelines to analyze it. However, there is still a lack of consensus standards in storing and sharing such data, generating diverse output files; hindering comparison between tools, data sharing, and development of downstream analyses independent of the tools used for miRNA detection and quantification. Here, we present a community based, open source project to work toward the standardization of miRNA pipelines and encourage the development of downstream tools for visualization, differential expression, sample clustering, and model prediction analyses. This project is an international collaboration, with experts from different countries that have been developing miRNA pipelines and resources. We have described a standard format for the output of miRNA detection and quantification tools using small RNA-seq data. The format is based on the GFF3 standard in order to support reference coordinates and parent/child relationships between the features. The format contains information foreach sequence and its annotation to the miRNA precursor, the definition of reference or isomiR sequence, its quality, the isomiR type, and abundance in the data set. Moreover, we support a command line python tool to manage the miRNA GFF3 format (miRTop). Currently, miRTop can convert the output of commonly used small RNA-Seq pipelines, such as seqbuster, isomiR-SEA, sRNAbench, and Prost!, as well as BAM files to the miRNA GFF3 format. Importantly, the miRge pipeline has adapted the GFF3 format natively. miRTop can convert miRNA GFF3 files to a count matrix that can be easily imported to any downstream tool (i.e. for differential expression analysis). Furthermore, the tool can export the miRNA GFF file to the isomiRs package, improving the usability of this tool and rendering it independent of the upstream methods used for quantifying miRNA sequences. Together, we believe that the miRTop project will improve accessibility and uniformity of the results oft miRNA pipelines, the possibility to easily run benchmarking analyses, and promote the development of miRNA tools downstream of the detection and quantification steps.","tags":["miRNA","isomiR"],"title":"miRTOP: An open source community project for the development of a unified format file for miRNA data","type":"talk"},{"authors":["Mercedes Rubio","Mariona Bustamante","Carles Hernandez-Ferrer","Dietmar Fernandez-Orth","Lorena Pantano","Yaris Sarria","Maria Piqu√©-Borras","Kilian Vellve","Silvia Agramunt","Ramon Carreras","Xavier Estivill","Juan R. Gonzalez","Alfredo Mayor"],"categories":null,"content":"","date":1514764800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1514764800,"objectID":"ce01d6e1e36a141f5f727501736e6036","permalink":"http://lpantano.github.io/publication/rubio-2018/","publishdate":"2019-09-08T18:14:44.083123Z","relpermalink":"/publication/rubio-2018/","section":"publication","summary":"Circulating small RNAs, including miRNAs but also isomiRs and other RNA species, have the potential to be used as non-invasive biomarkers for communicable and non-communicable diseases. This study aims to characterize and compare small RNA profiles in human biofluids. For this purpose, RNA was extracted from plasma and breast milk samples from 15 healthy postpartum mothers. Small RNA libraries were prepared with the NEBNexttextregistered small RNA library preparation kit and sequenced in an Illumina HiSeq2000 platform. miRNAs, isomiRs and clusters of small RNAs were annotated using seqBuster/seqCluster framework in 5 plasma and 10 milk samples that passed the initial quality control. The RNA yield was 81 ng/mL [standard deviation (SD): 41] and 3985 ng/mL (SD: 3767) for plasma and breast milk, respectively. Mean number of good quality reads was 4.04 million (M) (40.01% of the reads) in plasma and 12.5M (89.6%) in breast milk. One thousand one hundred eighty two miRNAs, 12,084 isomiRs and 1,053 small RNA clusters that included piwi-interfering RNAs (piRNAs), tRNAs, small nucleolar RNAs (snoRNA) and small nuclear RNAs (snRNAs) were detected. Samples grouped by biofluid, with 308 miRNAs, 1,790 isomiRs and 778 small RNA clusters differentially detected. In summary, plasma and milk showed a different small RNA profile. In both, miRNAs, piRNAs, tRNAs, snRNAs, and snoRNAs were identified, confirming the presence of non-miRNA species in plasma, and describing them for the first time in milk.","tags":null,"title":"Circulating miRNAs, isomiRs and small RNA clusters in human plasma and breast milk","type":"publication"},{"authors":["Michael J. Steinbaugh","Lorena Pantano","Rory D. Kirchner","Victor Barrera","Brad A. Chapman","Mary E. Piper","Meeta Mistry","Radhika S. Khetani","Kayleigh D. Rutherford","Oliver Hofmann","John N. Hutchinson","Shannan Ho Sui"],"categories":null,"content":"","date":1509494400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1509494400,"objectID":"e915cc49d229c856db39378ec1578117","permalink":"http://lpantano.github.io/publication/steinbaugh-2017/","publishdate":"2019-09-08T18:14:44.08528Z","relpermalink":"/publication/steinbaugh-2017/","section":"publication","summary":"RNA-seq analysis involves multiple steps from processing raw sequencing data to identifying, organizing, annotating, and reporting differentially expressed genes. bcbio is an open source, community-maintained framework providing automated and scalable RNA-seq methods for identifying gene abundance counts. We have developed bcbioRNASeq, a Bioconductor package that provides ready-to-render templates and wrapper functions to post-process bcbio output data. bcbioRNASeq automates the generation of high-level RNA-seq reports, including identification of differentially expressed genes, functional enrichment analysis and quality control analysis.","tags":null,"title":"bcbioRNASeq: R package for bcbio RNA-seq analysis","type":"publication"},{"authors":null,"categories":["Tutorials"],"content":"Video Tutorial Description https://www.meetup.com/Cambridge-woman-developers-in-bioinformatics/events/242964863/\nWatch on YouTube View on YouTube\n","date":1505310651,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1505310651,"objectID":"c53efc75df4345a66e2fa4fdd64be8e0","permalink":"http://lpantano.github.io/tutorials/2017-09-13-degreport-intro-a-tolkit-for-de-analysis/","publishdate":"2017-09-13T13:50:51Z","relpermalink":"/tutorials/2017-09-13-degreport-intro-a-tolkit-for-de-analysis/","section":"tutorials","summary":"https://www.meetup.com/Cambridge-woman-developers-in-bioinformatics/events/242964863/","tags":["tutorial","video"],"title":"DEGreport intro: a tolkit for DE analysis","type":"tutorial"},{"authors":null,"categories":null,"content":"This is a funny story, and I will try to tell you how I realized I don‚Äôt know anything about R in 400 words.\nI work at the Bioinformatic Core at Harvard TH School. People who know us, or collaborate with us, knows that we mainly use bcbio to analyze sequencing data (check it out, super cool tool).\nSomething that we are working on is to load the data after bcbio finishes into R to ease the downstream analysis. For instance, for RNA-seq we have bcbioRnaSeq and for small RNA-seq we have bcbioSmallRna. In short, these R packages make easy the task to load all the data generated by bcbio and wrap many methods and functions to generate the most used figures/analysis.\nThat is not the story. The story is that the bcbioRNADataSet object in those packages contains all the data in order to make easy the use of different counts matrix, or subset to a smaller samples/genes. For instance, the object contains the DDS object (DESeq2 DESeqDataSet), so we can use methods for this class or re-normalize at any point.\nWell, when we implemented the [ method (this allows to subset the object), we discovered that the object coming from that method was twice as big when saving into an RDA file. For instance, if you have an object with 34K genes, 100 samples that would be 900Mb when saving, then you subset to 1000 genes and 8 samples, you would end up with a file being 1.6G.\nThat is not nice, so I decided to play around. I don‚Äôt want you to read our code, because contains a lot of information, but feel free: subset. I value your time, so this is a dummy example.\nThe examples mainly creates different objects:\ndummyBig: 10K genes, 100 samples dummySmall: 500 genes, 5 samples dummySilly: subset of dummyBig using a silly function to subset, same size than dummySmall dummySmart: subset of dummyBig using a smart function to subset, same size than dummySmall We should expect that dummySilly and dummySmart have a similar size than dummySmall‚Ä¶\nThis is the size of RDA files for each of them (size in Kb):\nobject file rdaSize objSize dummyBig big.rda 2828.49 Kb 1588 Kb dummySmall micro.rda 24.19 Kb 42.6 Kb dummySilly microSilly.rda 4397.49 Kb 43.2 Kb dummySmart microSmart.rda 22.38 Kb 43.2 Kb rdaSize is the size of the file using save(obj, file = fileName.rda function. objSize is the size in memory in R using the function format(object.size(obj))\nAs you can see, microSilly is almost twice the original data, but microSmart is the expected size.\nI don‚Äôt know the exact reason, but the chunk of code that made the trick was to create an internal function to be called inside the method to re-generate the DESeq2 object with the smaller size.\nI know there should be a better way to avoid this, but this worked. If you have any comment/advice post it here. My R session is below.\n‚Äúhonesty in bioinformatics: accept you develop without being an expert and that creates chaos.‚Äù\nR version 3.4.1 (2017-06-30) Platform: x86_64-apple-darwin15.6.0 (64-bit) Running under: macOS Sierra 10.12.6 Matrix products: default BLAS: /Library/Frameworks/R.framework/Versions/3.4/Resources/lib/libRblas.0.dylib LAPACK: /Library/Frameworks/R.framework/Versions/3.4/Resources/lib/libRlapack.dylib locale: [1] en_US.UTF-8/en_US.UTF-8/en_US.UTF-8/C/en_US.UTF-8/en_US.UTF-8 attached base packages: [1] parallel stats4 methods stats graphics grDevices utils [8] datasets base other attached packages: [1] dplyr_0.7.2.9000 DESeq2_1.16.1 [3] SummarizedExperiment_1.6.3 DelayedArray_0.2.7 [5] matrixStats_0.52.2 Biobase_2.36.2 [7] GenomicRanges_1.28.4 GenomeInfoDb_1.12.2 [9] IRanges_2.10.2 S4Vectors_0.14.3 [11] BiocGenerics_0.22.0 loaded via a namespace (and not attached): [1] Rcpp_0.12.12 locfit_1.5-9.1 lattice_0.20-35 [4] assertthat_0.2.0 digest_0.6.12 R6_2.2.2 [7] plyr_1.8.4 backports_1.1.0 acepack_1.4.1 [10] RSQLite_2.0 highr_0.6 ggplot2_2.2.1 [13] zlibbioc_1.22.0 rlang_0.1.2.9000 lazyeval_0.2.0 [16] data.table_1.10.4 annotate_1.54.0 blob_1.1.0 [19] rpart_4.1-11 Matrix_1.2-10 checkmate_1.8.2 [22] splines_3.4.1 BiocParallel_1.10.1 geneplotter_1.54.0 [25] stringr_1.2.0 foreign_0.8-69 htmlwidgets_0.8 [28] RCurl_1.95-4.8 bit_1.1-12 munsell_0.4.3 [31] compiler_3.4.1 pkgconfig_2.0.1 base64enc_0.1-3 [34] htmltools_0.3.6 nnet_7.3-12 tibble_1.3.3.9001 [37] gridExtra_2.2.1 htmlTable_1.9 GenomeInfoDbData_0.99.0 [40] Hmisc_4.0-3 XML_3.98-1.9 bitops_1.0-6 [43] grid_3.4.1 xtable_1.8-2 gtable_0.2.0 [46] DBI_0.7 magrittr_1.5 scales_0.4.1 [49] stringi_1.1.5 XVector_0.16.0 genefilter_1.58.1 [52] bindrcpp_0.2 latticeExtra_0.6-28 Formula_1.2-1 [55] RColorBrewer_1.1-2 tools_3.4.1 bit64_0.9-7 [58] glue_1.1.1.9000 survival_2.41-3 AnnotationDbi_1.38.2 [61] colorspace_1.3-2 cluster_2.0.6 memoise_1.1.0 [64] bindr_0.1 knitr_1.17 ","date":1503525001,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1503525001,"objectID":"bd6ab42f0dac2f1d0969ea35593f94ab","permalink":"http://lpantano.github.io/post/legacy/2017-08-24-subset-object-creates-bigger-file/","publishdate":"2017-08-23T17:50:01-04:00","relpermalink":"/post/legacy/2017-08-24-subset-object-creates-bigger-file/","section":"post","summary":"This is a funny story, and I will try to tell you how I realized I don‚Äôt know anything about R in 400 words.\nI work at the Bioinformatic Core at Harvard TH School. People who know us, or collaborate with us, knows that we mainly use bcbio to analyze sequencing data (check it out, super cool tool).\n","tags":["R","develop"],"title":"Subset of object creates bigger RDA file size than original object","type":"post"},{"authors":null,"categories":null,"content":"Differentially gene expression analysis with RNA-seq data is quite common nowadays, and there are pretty good Bioconductor packages for that: limma::voom, DESeq2 ‚Ä¶\nThe code for that part is quite simple, being super quick to get a list of de-regulated genes. However, downstream analyses vary a lot depending on the project itself. But I found myself doing the same plots and analyses many times for different project, so I put together a bunch of plots and analyses using code from my colleagues at work (@HSPH bioinformatics core) and myself.\nThere are many possibilities, including QC figures, but the features that seem more interesting are:\nplot of individual genes using multiple variables from the metadata. This would be an evolution of plotCounts function from DESeq2. Fig1 plot volcano plots labeling some genes. Fig2 clustering set of genes to find common patterns expression. Most useful for time seria data. You get as well the list of genes that follows that pattern, so you can use it for functional analysis, for instance. Fig3 note: maybe some features only available with development version\nPackage available at BioC page\nThe code is available here\nHope you enjoy!\nAny suggestion and/or issue is welcome here\n‚Äúsincerity in bioinformatics: try hard to explain the limitation of your analysis to non-computational researchers‚Äù\n","date":1490046601,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1490046601,"objectID":"191c9b064dc5bc6142194d1170383eab","permalink":"http://lpantano.github.io/post/legacy/2017-03-20-degreport-rnaseq-figures/","publishdate":"2017-03-20T17:50:01-04:00","relpermalink":"/post/legacy/2017-03-20-degreport-rnaseq-figures/","section":"post","summary":"Differentially gene expression analysis with RNA-seq data is quite common nowadays, and there are pretty good Bioconductor packages for that: limma::voom, DESeq2 ‚Ä¶\nThe code for that part is quite simple, being super quick to get a list of de-regulated genes. However, downstream analyses vary a lot depending on the project itself. But I found myself doing the same plots and analyses many times for different project, so I put together a bunch of plots and analyses using code from my colleagues at work (@HSPH bioinformatics core) and myself.\n","tags":["viz","RNAseq","small RNAseq"],"title":"DEGreport to plot nice RNA-seq figures","type":"post"},{"authors":["Stuti Mehta","D. Alexander Cronkite","Megha Basavappa","Tahnee L. Saunders","Fatemeh Adiliaghdam","Hajera Amatullah","Sara A. Morrison","Jose D. Pagan","Robert M. Anthony","Pierre Tonnerre","Georg M. Lauer","James C. Lee","Sreehaas Digumarthi","Lorena Pantano","Shannan J. Ho Sui","Fei Ji","Ruslan Sadreyev","Chan Zhou","Alan C. Mullen","Vinod Kumar","Yang Li","Cisca Wijmenga","Ramnik J. Xavier","Terry K. Means","Kate L. Jeffrey"],"categories":null,"content":"","date":1488326400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1488326400,"objectID":"d075b4520106892042a1c7e279289796","permalink":"http://lpantano.github.io/publication/mehta-2017/","publishdate":"2019-09-08T18:14:44.084273Z","relpermalink":"/publication/mehta-2017/","section":"publication","summary":"Epigenetic \"readers\" that recognize defined posttranslational modifications on histones have become desirable therapeutic targets for cancer and inflammation. SP140 is one such bromodomain- and plant homeodomain (PHD)-containing reader with immune-restricted expression, and single-nucleotide polymorphisms (SNPs) within SP140 associate with Crohn's disease (CD). However, the function of SP140 and the consequences of disease-associated SP140 SNPs have remained unclear. We show that SP140 is critical for transcriptional programs that uphold the macrophage state. SP140 preferentially occupies promoters of silenced, lineage-inappropriate genes bearing the histone modification H3K27me3, such as the HOXA cluster in human macrophages, and ensures their repression. Depletion of SP140 in mouse or human macrophages resulted in severely compromised microbe-induced activation. We reveal that peripheral blood mononuclear cells (PBMCs) or B cells from individuals carrying CD-associated SNPs within SP140 have defective SP140 messenger RNA splicing and diminished SP140 protein levels. Moreover, CD patients carrying SP140 SNPs displayed suppressed innate immune gene signatures in a mixed population of PBMCs that stratified them from other CD patients. Hematopoietic-specific knockdown of Sp140 in mice resulted in exacerbated dextran sulfate sodium (DSS)-induced colitis, and low SP140 levels in human CD intestinal biopsies correlated with relatively lower intestinal innate cytokine levels and improved response to anti-tumor necrosis factor (TNF) therapy. Thus, the epigenetic reader SP140 is a key regulator of macrophage transcriptional programs for cellular state, and a loss of SP140 due to genetic variation contributes to a molecularly defined subset of CD characterized by ineffective innate immunity, normally critical for intestinal homeostasis.","tags":null,"title":"Maintenance of macrophage transcriptional programs and intestinal homeostasis by epigenetic reader SP140","type":"publication"},{"authors":["Kenneth Daily","Shannan J. Ho Sui","Lynn M. Schriml","Phillip J. Dexheimer","Nathan Salomonis","Robin Schroll","Stacy Bush","Mehdi Keddache","Christopher Mayhew","Samad Lotia","Thanneer M. Perumal","Kristen Dang","Lorena Pantano","Alexander R. Pico","Elke Grassman","Diana Nordling","Winston Hide","Antonis K. Hatzopoulos","Punam Malik","Jose A. Cancelas","Carolyn Lutzko","Bruce J. Aronow","Larsson Omberg"],"categories":null,"content":"","date":1488326400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1488326400,"objectID":"a1ed8a90262022fa3b38c21062b3701d","permalink":"http://lpantano.github.io/publication/daily-2017/","publishdate":"2019-09-08T18:14:44.087898Z","relpermalink":"/publication/daily-2017/","section":"publication","summary":"The use of induced pluripotent stem cells (iPSC) derived from independent patients and sources holds considerable promise to improve the understanding of development and disease. However, optimized use of iPSC depends on our ability to develop methods to efficiently qualify cell lines and protocols, monitor genetic stability, and evaluate self-renewal and differentiation potential. To accomplish these goals, 57 stem cell lines from 10 laboratories were differentiated to 7 different states, resulting in 248 analyzed samples. Cell lines were differentiated and characterized at a central laboratory using standardized cell culture methodologies, protocols, and metadata descriptors. Stem cell and derived differentiated lines were characterized using RNA-seq, miRNA-seq, copy number arrays, DNA methylation arrays, flow cytometry, and molecular histology. All materials, including raw data, metadata, analysis and processing code, and methodological and provenance documentation are publicly available for re-use and interactive exploration at https://www.synapse.org/pcbc. The goal is to provide data that can improve our ability to robustly and reproducibly use human pluripotent stem cells to understand development and disease.","tags":null,"title":"Molecular, phenotypic, and sample-associated data to describe pluripotent stem cell lines and derivatives","type":"publication"},{"authors":["E. Ransey","A. Bj√∂rkbom","V.S. Lelyveld","P. Biecek","L. Pantano","J.W. Szostak","P. Sliz"],"categories":null,"content":"","date":1483228800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1483228800,"objectID":"321d5c698b3ce99bc82f081cfcf32ac4","permalink":"http://lpantano.github.io/publication/ransey-2017/","publishdate":"2019-09-08T18:14:44.086249Z","relpermalink":"/publication/ransey-2017/","section":"publication","summary":"LLC It remains a formidable challenge to characterize the diverse complexes of RNA binding proteins and their targets. While crosslink and immunoprecipitation (CLIP) methods are powerful techniques that identify RNA targets on a global scale, the resolution and consistency of these methods is a matter of debate. Here we present a comparative analysis of LIN28-pre-let-7 UV-induced crosslinking using a tandem mass spectrometry (MS/MS) and deep sequencing interrogation of in vitro crosslinked complexes. Interestingly, analyses by the two methods diverge in their identification of crosslinked nucleotide identity ‚Äì whereas bioinformatics and sequencing analyses suggest guanine in mammalian cells, MS/MS identifies uridine. This work suggests the need for comprehensive analysis and validation of crosslinking methodologies.","tags":["CIMS","CLIP","LIN28"],"title":"Comparative analysis of LIN28-RNA binding sites identified at single nucleotide resolution","type":"publication"},{"authors":["Juan J. Carmona","William P. Accomando","Alexandra M. Binder","John N. Hutchinson","Lorena Pantano","Benedetta Izzi","Allan C. Just","Xihong Lin","Joel Schwartz","Pantel S. Vokonas","Sami S. Amr","Andrea A. Baccarelli","Karin B. Michels"],"categories":null,"content":"","date":1483228800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1483228800,"objectID":"59dd9bdc17d61d70b730e0d93ddeeb70","permalink":"http://lpantano.github.io/publication/carmona-2017/","publishdate":"2019-09-08T18:15:28.603596Z","relpermalink":"/publication/carmona-2017/","section":"publication","summary":"We empirically examined the strengths and weaknesses of two human genome-wide DNA methylation platforms: rapid multiplexed reduced representation bisulfite sequencing and Illumina's Infinium BeadChip. Rapid multiplexed reduced representation bisulfite sequencing required less input DNA, offered more flexibility in coverage, and interrogated more CpG loci at a higher regional density. The Infinium covered slightly more protein coding, cancer-associated and mitochondrial-related genes, both platforms covered all known imprinting clusters, and rapid multiplexed reduced representation bisulfite sequencing covered more microRNA genes than the HumanMethylation450, but fewer than the MethylationEPIC. Rapid multiplexed reduced representation bisulfite sequencing did not always interrogate exactly the same CpG loci, but genomic tiling improved overlap between different libraries. Reproducibility of rapid multiplexed reduced representation bisulfite sequencing and concordance between the platforms increased with CpG density. Only rapid multiplexed reduced representation bisulfite sequencing could genotype samples and measure allele-specific methylation, and we confirmed that Infinium measurements are influenced by nearby single-nucleotide polymorphisms. The respective strengths and weaknesses of these two genome-wide DNA methylation platforms need to be considered when conducting human epigenetic studies.","tags":["selected"],"title":"Empirical comparison of reduced representation bisulfite sequencing and Infinium BeadChip reproducibility and coverage of DNA methylation in humans","type":"publication"},{"authors":["B. Busby","E.M. Weitz","L. Pantano","J. Zhu","B. Upton"],"categories":null,"content":"","date":1483228800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1483228800,"objectID":"92eb06c2b5580dbb666a92795ca1e4bf","permalink":"http://lpantano.github.io/publication/busby-2017/","publishdate":"2019-09-08T18:14:44.087058Z","relpermalink":"/publication/busby-2017/","section":"publication","summary":"RNA-Seq Viewer is a web application that enables users to visualize genome-wide expression data from NCBI's Sequence Read Archive (SRA) and Gene Expression Omnibus (GEO) databases. The application prototype was created by a small team during a three-day hackathon facilitated by NCBI at Brandeis University. The backend data pipeline was developed and deployed on a shared AWS EC2 instance. Source code is available at https://github.com/NCBI-Hackathons/rnaseqview.","tags":["Ideogram","Javascript","Next generation sequencing","RNA-seq"],"title":"Viewing RNA-seq data on the entire human genome","type":"publication"},{"authors":["Lorena Pantano","Brad Chapman","Rory Kirchner","John Hutchinson","Oliver Hofmann","Shannon Ho Sui"],"categories":null,"content":"","date":1468072457,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1468072457,"objectID":"86ba4155e95cf2fa9b353aac6a2919df","permalink":"http://lpantano.github.io/talk/bosc2016/","publishdate":"2016-07-09T14:54:17+01:00","relpermalink":"/talk/bosc2016/","section":"talk","summary":"The study of small RNA helps us understand some of the complexity of gene regulation of a cell. Of the different types of small RNAs, the most important in mammals are miRNA, tRNA fragments and piRNAs. The advantage of small RNA-seq analysis is that we can study all small RNA types simultaneously, with the potential to detect novel small RNAs. bcbio-nextgen is a community- developed Python framework that implements best practices for next-generation sequence data analysis and uses gold standard data for validation. We have extended bcbio to include a small RNA-seq analysis pipeline that performs quality control, removal of adapter contamination, annotation of miRNA, isomiRs and tRNAs, novel miRNA discovery, and genome-wide characterization of other types of small RNAs. The pipeline integrates tools such as miRDeep2, seqbuster, seqcluster and tdrMapper to facilitate annotation to small RNA categories. It produces an R Markdown template that helps with downstream statistical analyses in R, including quality control metrics and best practices for differential expression and clustering analyses. Finally, the pipeline generates an interactive HTML-based browser for visualization purposes. This is useful for characterizing novel small RNA types, working with non-model organisms, or providing a general profiling description. This browser shows the small RNA regions along with their genomic annotation, expression profile over the precursor, secondary structure, and the top expressed sequences. Here, we show the capabilities of the pipeline and validation using data from the miRQC project. We show that the quantification accuracy is around 95% for miRNAs. We obtained similar results for other types of small RNA molecules, demonstrating that we can reliably detect small RNAs without a dependency on specific databases.","tags":[],"title":"Characterization of the small RNA transcriptome using the bcbio-nextgen python framework","type":"talk"},{"authors":null,"categories":null,"content":"In summary: I will show which is the best miRNA mapping tool. I used several options¬†for this benchmarking:\nmiraligner from¬†SeqBuster¬†suit (I am one of the authors) bowtie2 and bowtie novoalign¬†from novocraft suit GEM srnabench microrazer STAR miRExpress I think that these are the most used, and other not used but good to try them. They were clearly developed for other purposes, but as well, they generate the input of many miRNA pipelines. I just wanted to know how well my tool was doing. The first aim to develop miraligner was to get annotated additions of nucleotides at the end of miRNA sequences, something that is very common in mirna biogenesis: isomirs¬†and often they are missed by short read and fast mappers. I have a¬†repository¬†for this kind of things, so anybody can reproduce my results, and check if I did something wrong, or comment on it. In this post I just want to know which tool detects more miRNA, for that I did two main steps:\nsimulate a bunch of miRNAs (isomirs) with my python¬†script¬†that is part of SeqBuster suit. I generated around 10000 sequences. Normally, one small-RNAseq library¬†produces around half million different sequences. use only miRBase human precursors as reference genome I used default parameter for all, so probably there is a set of parameters that would be better for some tools, but I didn‚Äôt search for them this time (happy to accept issues to add them). The¬†results¬†are:\nmiraligner and STAR map more sequences. miraligner loses sequences shorter than 15 nt, normally (miRNA) are around 21, and those sequences map to repeat elements STAR is the best mapping, but need some parsing to reduce false positive. I think that pipelines should change to this tool. GEM has problems with additions and nt substitutions in many cases, same as novoaligner (I will look at this in the future) bowtie2/bowtie is the second that annotated most (and best) microrazer has a problem with mismatches, but maybe there is some parameter to trick miRExpress with default options only will map perfect matches sequences to precursor, so strongly recommended to allow errors to increase sensibility. I have to say that the advantage of miraligner is that it gives you the sequence annotated as miRNA or precursor, and gives you the exactly modifications that sequences have if they are compared to miRBase database. And you could feed the results to my R package to plot isomers distribution of samples from different groups, and do differential expression analysis with DESeq2, or another tool. I didn‚Äôt add time consumption because all of them run in a couple of minutes. In my next post I will focus in the the correct annotation of each sequence, and the possible problems with cross-mapping events, when the sequence comes from another regions of the genome but map to miRBase precursor as well [see my previous¬†post¬†for more details]. As well I will use STAR with the full genome and see if the mapping continues being the best. In that case I will add a script to SeqBuster to parse the output of STAR for those who can map with STAR (need up to 32G for human genome)\n","date":1458863341,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1458863341,"objectID":"668958435b87a09c9705e59cf5eaabc9","permalink":"http://lpantano.github.io/post/legacy/2016-03-24-mirna-annotation-tools-comparison/","publishdate":"2016-03-24T19:49:01-04:00","relpermalink":"/post/legacy/2016-03-24-mirna-annotation-tools-comparison/","section":"post","summary":"In summary: I will show which is the best miRNA mapping tool. I used several options¬†for this benchmarking:\nmiraligner from¬†SeqBuster¬†suit (I am one of the authors) bowtie2 and bowtie novoalign¬†from novocraft suit GEM srnabench microrazer STAR miRExpress I think that these are the most used, and other not used but good to try them. They were clearly developed for other purposes, but as well, they generate the input of many miRNA pipelines. I just wanted to know how well my tool was doing. The first aim to develop miraligner was to get annotated additions of nucleotides at the end of miRNA sequences, something that is very common in mirna biogenesis: isomirs¬†and often they are missed by short read and fast mappers. I have a¬†repository¬†for this kind of things, so anybody can reproduce my results, and check if I did something wrong, or comment on it. In this post I just want to know which tool detects more miRNA, for that I did two main steps:\n","tags":["miRNA"],"title":"miRNA Annotation Tools Comparison","type":"post"},{"authors":["P Bailey","D K Chang","K Nones","A L Johns","A M Patch","M C Gingras","D K Miller","A N Christ","T J Bruxner","M C Quinn","C Nourse","L C Murtaugh","I Harliwong","S Idrisoglu","S Manning","E Nourbakhsh","S Wani","L Fink","O Holmes","V Chin","M J Anderson","S Kazakoff","C Leonard","F Newell","N Waddell","S Wood","Q Xu","P J Wilson","N Cloonan","K S Kassahn","D Taylor","K Quek","A Robertson","L Pantano","L Mincarelli","L N Sanchez","L Evers","J Wu","M Pinese","M J Cowley","M D Jones","E K Colvin","A M Nagrial","E S Humphrey","L A Chantrill","A Mawson","J Humphris","A Chou","M Pajic","C J Scarlett","A V Pinho","M Giry-Laterriere","I Rooman","J S Samra","J G Kench","J A Lovell","N D Merrett","C W Toon","K Epari","N Q Nguyen","A Barbour","N Zeps","K Moran-Jones","N B Jamieson","J S Graham","F Duthie","K Oien","J Hair","R Grutzmann","A Maitra","C A Iacobuzio-Donahue","C L Wolfgang","R A Morgan","R T Lawlor","V Corbo","C Bassi","B Rusev","P Capelli","R Salvia","G Tortora","D Mukhopadhyay","G M Petersen","Initiative Australian Pancreatic Cancer Genome","D M Munzy","W E Fisher","S A Karim","J R Eshleman","R H Hruban","C Pilarsky","J P Morton","O J Sansom","A Scarpa","E A Musgrove","U M Bailey","O Hofmann","R L Sutherland","D A Wheeler","A J Gill","R A Gibbs","J V Pearson","N Waddell","A V Biankin","S M Grimmond"],"categories":null,"content":"","date":1451606400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1451606400,"objectID":"0c933b1ce5c119e723f6c876ad2df6ff","permalink":"http://lpantano.github.io/publication/bailey-2016/","publishdate":"2019-09-08T18:14:44.088896Z","relpermalink":"/publication/bailey-2016/","section":"publication","summary":"Integrated genomic analysis of 456 pancreatic ductal adenocarcinomas identified 32 recurrently mutated genes that aggregate into 10 pathways: KRAS, TGF-beta, WNT, NOTCH, ROBO/SLIT signalling, G1/S transition, SWI-SNF, chromatin modification, DNA repair and RNA processing. Expression analysis defined 4 subtypes: (1) squamous; (2) pancreatic progenitor; (3) immunogenic; and (4) aberrantly differentiated endocrine exocrine (ADEX) that correlate with histopathological characteristics. Squamous tumours are enriched for TP53 and KDM6A mutations, upregulation of the TP63N transcriptional network, hypermethylation of pancreatic endodermal cell-fate determining genes and have a poor prognosis. Pancreatic progenitor tumours preferentially express genes involved in early pancreatic development (FOXA2/3, PDX1 and MNX1). ADEX tumours displayed upregulation of genes that regulate networks involved in KRAS activation, exocrine (NR5A2 and RBPJL), and endocrine differentiation (NEUROD1 and NKX2-2). Immunogenic tumours contained upregulated immune networks including pathways involved in acquired immune suppression. These data infer differences in the molecular evolution of pancreatic cancer subtypes and identify opportunities for therapeutic development.","tags":["*Genomics","Animals","Basic Helix-Loop-Helix Transcription Factors/genet","Carcinoma","Pancreatic","Cell Line","Tumor","DNA Methylation","DNA-Binding Proteins/genetics","Ductal/classification/genetics/immunology/metaboli","Gene Expression Regulation","Neoplastic","Gene Regulatory Networks","Genes","Neoplasm/*genetics","Genome","Human/*genetics","Hepatocyte Nuclear Factor 3-beta/genetics","Hepatocyte Nuclear Factor 3-gamma/genetics","Histone Demethylases/genetics","Homeodomain Proteins/genetics","Humans","Mice","Mutation/*genetics","Nuclear Proteins/genetics","Pancreatic Neoplasms/*classification/*genetics/imm","Prognosis","Receptors","Cytoplasmic and Nuclear/genetics","Survival Analysis","Trans-Activators/genetics","Transcription Factors/genetics","Transcription","Genetic","Transcriptome","Tumor Suppressor Protein p53/genetics","Tumor Suppressor Proteins/genetics"],"title":"Genomic analyses identify molecular subtypes of pancreatic cancer","type":"publication"},{"authors":["Lorena Pantano","Marc R Friedlander","Georgia Escaramis","Esther Lizano","Joan Pallares-Albanell","Isidre Ferrer","Xavier Estivill","Eulalia Marti"],"categories":null,"content":"","date":1446336000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1446336000,"objectID":"d300416ed632cdf4483de8dc5824ee02","permalink":"http://lpantano.github.io/publication/pantano-2015/","publishdate":"2019-09-08T18:15:28.605092Z","relpermalink":"/publication/pantano-2015/","section":"publication","summary":"MOTIVATION: Most computational tools for small non-coding RNAs (sRNA) sequencing data analysis focus in microRNAs (miRNAs), overlooking other types of sRNAs that show multi-mapping hits. Here, we have developed a pipeline to non-redundantly quantify all types of sRNAs, and extract patterns of expression in biologically defined groups. We have used our tool to characterize and profile sRNAs in post-mortem brain samples of control individuals and Parkinson's disease (PD) cases at early-premotor and late-symptomatic stages. RESULTS: Clusters of co-expressed sRNAs mapping onto tRNAs significantly separated premotor and motor cases from controls. A similar result was obtained using a matrix of miRNAs slightly varying in sequence (isomiRs). The present framework revealed sRNA alterations at premotor stages of PD, which might reflect initial pathogenic perturbations. This tool may be useful to discover sRNA expression patterns linked to different biological conditions. AVAILABILITY AND IMPLEMENTATION: The full code is available at http://github.com/lpantano/seqbuster. CONTACT: lpantano@hsph.harvard.edu or eulalia.marti@crg.euSupplementary information: Supplementary data are available at Bioinformatics online.","tags":["bcbio-srnaseq","selected","srna-methods"],"title":"Specific small-RNA signatures in the amygdala at premotor and motor stages of Parkinson's disease revealed by deep sequencing analysis.","type":"publication"},{"authors":["Lorena Pantano","Meritxell Jodar","Mads Bak","Josep Llu√≠s Ballesc√†","Niels Tommerup","Rafael Oliva","Tanya Vavouri"],"categories":null,"content":"","date":1433116800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1433116800,"objectID":"2c8bd4dd377e456a109f8cff0c7cd89a","permalink":"http://lpantano.github.io/publication/pantano-2015-a/","publishdate":"2019-09-08T18:15:28.604162Z","relpermalink":"/publication/pantano-2015-a/","section":"publication","summary":"At the end of mammalian sperm development, sperm cells expel most of their cytoplasm and dispose of the majority of their RNA. Yet, hundreds of RNA molecules remain in mature sperm. The biological significance of the vast majority of these molecules is unclear. To better understand the processes that generate sperm small RNAs and what roles they may have, we sequenced and characterized the small RNA content of sperm samples from two human fertile individuals. We detected 182 microRNAs, some of which are highly abundant. The most abundant microRNA in sperm is miR-1246 with predicted targets among sperm-specific genes. The most abundant class of small noncoding RNAs in sperm are PIWI-interacting RNAs (piRNAs). Surprisingly, we found that human sperm cells contain piRNAs processed from pseudogenes. Clusters of piRNAs from human testes contain pseudogenes transcribed in the antisense strand and processed into small RNAs. Several human protein-coding genes contain antisense predicted targets of pseudogene-derived piRNAs in the male germline and these piRNAs are still found in mature sperm. Our study provides the most extensive data set and annotation of human sperm small RNAs to date and is a resource for further functional studies on the roles of sperm small RNAs. In addition, we propose that some of the pseudogene-derived human piRNAs may regulate expression of their parent gene in the male germline.","tags":["Humans","Long Interspersed Nucleotide Elements","Male","MicroRNAs","MicroRNAs: genetics","Phylogeny","Promoter Regions","Genetic","Proteins","Proteins: metabolism","Pseudogenes","RNA","Small Interfering","RNA","Small Interfering: genetics","RNA","Small Interfering: metabolism","Sequence Analysis","RNA","Sequence Analysis","RNA: methods","Spermatozoa","Spermatozoa: metabolism","Testis","Testis: metabolism","selected"],"title":"The small RNA content of human sperm reveals pseudogene-derived piRNAs complementary to protein-coding genes.","type":"publication"},{"authors":["Marta Puig","David Castellano","Lorena Pantano","Carla Giner-Delgado","David Izquierdo","Magdalena Gay√†-Vidal","Jos√© Ignacio Lucas-Lled√≥","T√µnu Esko","Chikashi Terao","Fumihiko Matsuda","Mario C√°ceres"],"categories":null,"content":"","date":1420070400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1420070400,"objectID":"4cae951b1a5664dd92393a5468950c86","permalink":"http://lpantano.github.io/publication/puig-2015/","publishdate":"2019-09-08T18:14:44.089904Z","relpermalink":"/publication/puig-2015/","section":"publication","summary":"Despite many years of study into inversions, very little is known about their functional consequences, especially in humans. A common hypothesis is that the selective value of inversions stems in part from their effects on nearby genes, although evidence of this in natural populations is almost nonexistent. Here we present a global analysis of a new 415-kb polymorphic inversion that is among the longest ones found in humans and is the first with clear position effects. This inversion is located in chromosome 19 and has been generated by non-homologous end joining between blocks of transposable elements with low identity. PCR genotyping in 541 individuals from eight different human populations allowed the detection of tag SNPs and inversion genotyping in multiple populations worldwide, showing that the inverted allele is mainly found in East Asia with an average frequency of 4.7%. Interestingly, one of the breakpoints disrupts the transcription factor gene ZNF257, causing a significant reduction in the total expression level of this gene in lymphoblastoid cell lines. RNA-Seq analysis of the effects of this expression change in standard homozygotes and inversion heterozygotes revealed distinct expression patterns that were validated by quantitative RT-PCR. Moreover, we have found a new fusion transcript that is generated exclusively from inverted chromosomes around one of the breakpoints. Finally, by the analysis of the associated nucleotide variation, we have estimated that the inversion was generated ÃÉ40,000-50,000 years ago and, while a neutral evolution cannot be ruled out, its current frequencies are more consistent with those expected for a deleterious variant, although no significant association with phenotypic traits has been found so far.","tags":null,"title":"Functional Impact and Evolution of a Novel Human Polymorphic Inversion That Disrupts a Gene and Creates a Fusion Transcript","type":"publication"},{"authors":["Anita √ñst","Adelheid Lempradl","Eduard Casas","Melanie Weigert","Theodor Tiko","Merdin Deniz","Lorena Pantano","Ulrike Boenisch","Pavel M. Itskov","Marlon Stoeckius","Marius Ruf","Nikolaus Rajewsky","Gunter Reuter","Nicola Iovino","Carlos Ribeiro","Mattias Alenius","Steffen Heyne","Tanya Vavouri","J. Andrew Pospisilik"],"categories":null,"content":"","date":1417392000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1417392000,"objectID":"b42ed4599a286f4f50362ec994a79511","permalink":"http://lpantano.github.io/publication/ost-2014/","publishdate":"2019-09-08T18:14:44.090518Z","relpermalink":"/publication/ost-2014/","section":"publication","summary":"The global rise in obesity has revitalized a search for genetic and epigenetic factors underlying the disease. We present a Drosophila model of paternal-diet-induced intergenerational metabolic reprogramming (IGMR) and identify genes required for its encoding in offspring. Intriguingly, we find that as little as 2 days of dietary intervention in fathers elicits obesity in offspring. Paternal sugar acts as a physiological suppressor of variegation, desilencing chromatin-state-defined domains in both mature sperm and in offspring embryos. We identify requirements for H3K9/K27me3-dependent reprogramming of metabolic genes in two distinct germline and zygotic windows. Critically, we find evidence that a similar system may regulate obesity susceptibility and phenotype variation in mice and humans. The findings provide insight into the mechanisms underlying intergenerational metabolic reprogramming and carry profound implications for our understanding of phenotypic variation and evolution.","tags":["Animals","Carbohydrate Metabolism","Diet","Disease Models","Animal","Drosophila melanogaster","Drosophila melanogaster: genetics","Drosophila melanogaster: metabolism","Embryo","Nonmammalian","Embryo","Nonmammalian: metabolism","Epigenesis","Genetic","Eye Color","Female","Genetic Predisposition to Disease","Heterochromatin","Heterochromatin: metabolism","Humans","Male","Mice","Obesity","Obesity: genetics","Obesity: metabolism","Spermatozoa","Spermatozoa: metabolism"],"title":"Paternal Diet Defines Offspring Chromatin State and Intergenerational Obesity","type":"publication"},{"authors":["Alexander Mart√≠nez-Fundichely","S√≤nia Casillas","Raquel Egea","Miquel R√†mia","Antonio Barbadilla","Lorena Pantano","Marta Puig","Mario C√°ceres"],"categories":null,"content":"","date":1388534400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1388534400,"objectID":"f8d8d7bc80f85a43bbdc8ee98163aa0c","permalink":"http://lpantano.github.io/publication/martinez-fundichely-2014/","publishdate":"2019-09-08T18:14:44.098728Z","relpermalink":"/publication/martinez-fundichely-2014/","section":"publication","summary":"The newest genomic advances have uncovered an unprecedented degree of structural variation throughout genomes, with great amounts of data accumulating rapidly. Here we introduce InvFEST (http://invfestdb.uab.cat), a database combining multiple sources of information to generate a complete catalogue of non-redundant human polymorphic inversions. Due to the complexity of this type of changes and the underlying high false-positive discovery rate, it is necessary to integrate all the available data to get a reliable estimate of the real number of inversions. InvFEST automatically merges predictions into different inversions, refines the breakpoint locations, and finds associations with genes and segmental duplications. In addition, it includes data on experimental validation, population frequency, functional effects and evolutionary history. All this information is readily accessible through a complete and user-friendly web report for each inversion. In its current version, InvFEST combines information from 34 different studies and contains 1092 candidate inversions, which are categorized based on internal scores and manual curation. Therefore, InvFEST aims to represent the most reliable set of human inversions and become a central repository to share information, guide future studies and contribute to the analysis of the functional and evolutionary impact of inversions on the human genome.","tags":null,"title":"InvFEST, a database integrating information of polymorphic inversions in the human genome","type":"publication"},{"authors":["Hedda A Meijer","Ewan M Smith","Martin Bushell","A. Kozomara","S. Griffiths-Jones","V.N. Kim","J. Han","M.C. Siomi","Y. Wang","S. Juranek","H. Li","G. Sheng","G.S. Wardle","T. Tuschl","D.J. Patel","S.W. Chi","J.B. Zang","A. Mele","R.B. Darnell","M. Hafner","M. Landthaler","L. Burger","M. Khorshid","J. Hausser","P. Berninger","A. Rothballer","M. Ascano","A.-C. Jungkamp","M. Munschauer","S. Djuranovic","A. Nahvi","R. Green","E. Huntzinger","D. Kuzuoƒülu-√ñzt√ºrk","J.E. Braun","A. Eulalio","L. Wohbold","E. Izaurralde","Q. Liu","P.J. Halvey","Y. Shyr","R.J.C. Slebos","D.C. Liebler","B. Zhang","H.A. Meijer","Y.W. Kong","W.T. Lu","A. Wilczynska","R.V. Spriggs","S.W. Robinson","J.D. Godfrey","A.E. Willis","M. Bushell","J. Krol","I. Loedige","W. Filipowicz","M. Biasiolo","G. Sales","M. Lionetti","L. Agnelli","K. Todoerti","A. Bisognin","A. Coppe","C. Romualdi","A. Neri","S. Bortoluzzi","M. He","Y. Liu","X. Wang","M.Q. Zhang","G. Hannon","Z.J. Huang","A. Mathelier","A. Carbone","F.V. Rivas","N.H. Tolia","J.-J. Song","J.P. Aragon","J. Liu","G.J. Hannon","L. Joshua-Tor","N. Tahbaz","F.A. Kolb","H. Zhang","K. Jaronczyk","W. Filipowicz","T.C. Hobman","J.M. Pare","N. Tahbaz","J. L√≥pez-Orozco","P. LaPointe","P. Lasko","T.C. Hobman","C.L. Noland","J.A. Doudna","S. Gu","L. Jin","F. Zhang","Y. Huang","D. Grimm","J.J. Rossi","M.A. Kay","S. Iwasaki","M. Kobayashi","M. Yoda","Y. Sakaguchi","S. Katsuma","T. Suzuki","Y. Tomari","E. Elkayam","C.-D. Kuhn","A. Tocilj","A.D. Haase","E.M. Greene","G.J. Hannon","L. Joshua-Tor","M. Yoda","T. Kawamata","Z. Paroo","X. Ye","S. Iwasaki","Q. Liu","Y. Tomari","P.B. Kwak","Y. Tomari","C. Matranga","Y. Tomari","C. Shin","D.P. Bartel","P.D. Zamore","D.S. Schwarz","G. Hutv√°gner","T. Du","Z. Xu","N. Aronin","P.D. Zamore","J. Krol","K. Sobczak","U. Wilczynska","M. Drath","A. Jasinska","D. Kaczynska","W.J. Krzyzosiak","A.S. O'Toole","S. Miller","N. Haines","M.C. Zink","M.J. Serra","S. Miller","L.E. Jones","K. Giovannitti","D. Piper","M.J. Serra","H.Y. Hu","Y. Zheng","Y. Xu","H. Hu","C. Menzel","Y.H. Zhou","W. Chen","P. Khaitovich","M. Ohanian","D.T. Humphreys","E. Anderson","T. Preiss","D. Fatkin","E. Marti","L. Pantano","M. Ba√±ez-Coronel","F. Llorens","E. Mi√±ones-Moyano","S. Porta","L. Sumoy","I. Ferrer","X. Estivill","C.T. Neilsen","G.J. Goodall","C.P. Bracken","D.T. Humphreys","C.J. Hynes","H.R. Patel","G.H. Wei","L. Cannon","D. Fatkin","C.M. Suter","J.L. Clancy","T. Preiss","H. Zhou","M.L. Arcila","Z. Li","E.J. Lee","C. Henzler","J. Liu","T.M. Rana","K.S. Kosik","M. Xie","M. Li","A. Vilborg","N. Lee","M.-D. Shu","V. Yartseva","N. Sestan","J.A. Steitz","H.Y. Lee","K. Zhou","A.M. Smith","C.L. Noland","J.A. Doudna","J. Winter","S. Diederichs","J.-S. Yang","M.D. Philips","D. Betel","P. Mu","A. Ventura","A.C. Siepel","K.C. Chen","E.C. Lai","L. Guo","Z. Lu","S. Ro","C. Park","D. Young","K.M. Sanders","W. Yan","H.R. Chiang","L.W. Schoenfeld","J.G. Ruby","V.C. Auyeung","N. Spies","D. Baek","W.K. Johnston","C. Russ","S. Luo","J.E. Babiarz","S. Bortoluzzi","A. Bisognin","M. Biasiolo","P. Guglielmelli","F. Biamonte","R. Norfo","R. Manfredini","A.M. Vannucchi","S. Griffiths-Jones","J.H.L. Hui","A. Marco","M. Ronshaugen","A.N. Packer","Y. Xing","S.Q. Harper","L. Jones","B.L. Davidson","L. Jiang","C. Lin","L. Song","J. Wu","B. Chen","Z. Ying","L. Fang","X. Yan","M. He","J. Li","M. Li","M. Rubio","R. Monta√±ez","L. Perez","M. Milan","X. Belles","S.W. Shan","L. Fang","T. Shatseva","Z.J. Rutnam","X. Yang","W.W. Du","W.-Y. Lu","J.W. Xuan","Z. Deng","B.B. Yang","X. Yang","W.W. Du","H. Li","F. Liu","A. Khorshidi","Z.J. Rutnam","B.B. Yang","H. Zhou","X. Huang","H. Cui","X. Luo","Y. Tang","S. Chen","L. Wu","N. Shen","L. Tarassishin","O. Loudig","A. Bauman","B. Shafit-Zagardo","H.-S. Suh","S.C. Lee","C.B. Giles","R. Girija-Devi","M.G. Dozmorov","J.D. Wren","S. Chatterjee","M. Fasier","I. B√ºssing","H. Gro$\beta$hans","M.P. Gantier","C.E. McCoy","I. Rusinova","D. Saulep","D. Wang","D. Xu","A.T. Irving","M.A. Behlke","P.J. Hertzog","F. Mackay","B.R.J. Williams","J. Krol","V. Busskamp","I. Markiewicz","M.B. Stadler","S. Ribi","J. Richter","J. Duebel","S. Bicker","H.J. Fehling","D. Schrubeler","T.S. Miki","H. Grosshans","S. Balaraman","E.R. Lunde","O. Sawant","T.A. Cudd","S.E. Washburn","R.C. Miranda"],"categories":null,"content":"","date":1388534400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1388534400,"objectID":"2e13ab4ad024cb680a02995585331c35","permalink":"http://lpantano.github.io/publication/meijer-2014/","publishdate":"2019-09-08T18:14:44.091706Z","relpermalink":"/publication/meijer-2014/","section":"publication","summary":"miRNA strand selection is the process that determines which of the two strands in a miRNA duplex becomes the active strand that is incorporated into the RISC (RNA-induced silencing complex) (named the guide strand, leading strand or miR) and which one gets degraded (the passenger strand or miR*). Thermodynamic features of the duplex appear to play an important role in this decision; the strand with the weakest binding at its 5'-end is more likely to become the guide strand. Other key characteristics of human miRNA guide strands are a U-bias at the 5'-end and an excess of purines, whereas the passenger strands have a C-bias at the 5'-end and an excess of pyrimidines. Several proteins are known to play a role in strand selection [Ago (Argonaute), DICER, TRBP (trans-activation response RNA-binding protein), PACT (protein activator of dsRNA-dependent protein kinase) and Xrn-1/2]; however, the mechanisms by which these proteins act are largely unknown. For several miRNAs the miR/miR* ratio varies dependent on cell type, developmental stage and in different disease states, suggesting that strand selection is a tightly controlled process. The present review discusses our current knowledge regarding the factors and processes involved in strand selection and the many questions that still remain.","tags":null,"title":"Regulation of miRNA strand selection: follow the leader?","type":"publication"},{"authors":null,"categories":null,"content":"My PhD was focused on small RNA sequencing data. I had a problem when I wanted to visualized the amount of small RNAs from the beginning. Here the problem, assume that you have a certain distribution of small RNA sequences abundance:\nseq1: 1500 times\nseq2: 3 times\nseq3: 2 times\nAnd you want to show the nucleotide composition of the first nucleotide. You can do it either counting the # of sequences (or abundance) in your set (1505) or the number of unique (different) sequences (3). You result will be very bias depending on that. If you go for the first option, you can obtain:\nand if you go for the second option:\nWhich is the best option? well, although papers in small RNA data still continue showing the first option, I think that this should be validated some way.\nWhen using unique sequences (only counting different sequences), you can under-estimated the real signal. In NGS, you can have a lot of noise, that may hide the biological signal using this approach. But, you can get the same, if you use directly the abundance, because if your set contains one sequence that is 90% of the data, you will get always a signal, that may be not important, for instance, ribosomal RNA that is expected to be there.\nOne solution is to plot the data according both values: percentage of abundance and percentage of unique sequences. And you can do this for each position and nucleotide.\nWe can conclude that at position 1, there are few sequences starting with A that are¬†90 of the data. Also we can see how the 60% of unique sequences have a G at position 10. This helps us to catch any biological signature if it exists, and avoid the misleading information in this kind of figures.\n","date":1383048356,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1383048356,"objectID":"49bf3a736fdc3be5fd976cfa4a92b6e8","permalink":"http://lpantano.github.io/post/legacy/2013-10-29-small-rna-abundance-miss-viz/","publishdate":"2013-10-29T08:05:56-04:00","relpermalink":"/post/legacy/2013-10-29-small-rna-abundance-miss-viz/","section":"post","summary":"My PhD was focused on small RNA sequencing data. I had a problem when I wanted to visualized the amount of small RNAs from the beginning. Here the problem, assume that you have a certain distribution of small RNA sequences abundance:\n","tags":["miRNA","small RNA"],"title":"small RNA abundance [miss-] viz","type":"post"},{"authors":null,"categories":null,"content":"What is the lying factor in figures?\nIt is the ratio between the difference of two numbers and the difference of the visualization of those two numbers. For instance:\nYou have two groups, each group is represented by 4 and 2. The difference between 4 and 2 is 2. Since ‚Äúa picture is worth a thousand words‚Äù, someone decides to represents those groups in a figure (yes, in excel to make it worst):\nThat figure shows a difference of 4 between the two groups. Since 4 is twice than 2, we have a lying factor of 2.\nProbably you think that this is not happening anywhere, it is ridiculous. It is, but probably you will find one of these cases in the news every day.\nMoreover, this is happening in science as well. For instance a (Nature)¬†paper which explains how authors are improving a method that analyzes NGS data.\nThey visualised a matrix correlation of the data using one method or another (b or c).\n![Screen Shot 2013-08-05 at 12.15.55 PM]({{ site.url }}/assets/screen-shot-2013-08-05-at-12-15-55-pm.png)\nIf you only read colours, you won‚Äôt see much difference, but there is. The problem was to use a different colour scale to show the same type of data. Probably they were produced separately, so the command to produce those figures (probably an R function) had to guess the scale by its own, resulting that 0.89 is equal to 0.75 .\nI leave my post here, and may say: take some time to think about it.\nsource:http://dx.doi.org/10.1038/nbt.2596\n","date":1375889785,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1375889785,"objectID":"172b65df59f74f3ca50f58404e371c58","permalink":"http://lpantano.github.io/post/legacy/2013-08-07-lying-factor-in-figures/","publishdate":"2013-08-07T11:36:25-04:00","relpermalink":"/post/legacy/2013-08-07-lying-factor-in-figures/","section":"post","summary":"What is the lying factor in figures?\nIt is the ratio between the difference of two numbers and the difference of the visualization of those two numbers. For instance:\nYou have two groups, each group is represented by 4 and 2. The difference between 4 and 2 is 2. Since ‚Äúa picture is worth a thousand words‚Äù, someone decides to represents those groups in a figure (yes, in excel to make it worst):\n","tags":["viz"],"title":"Lying factor in figures","type":"post"},{"authors":null,"categories":null,"content":"Everybody who is working with microRNA knows about miRBase, it was the first miRNA catalogue. Everybody is using it to annotate small RNA sequences as miRNA or not. And it is great, and very helpfully‚Ä¶but there are some cases that we should investigate our results.\nFor instance, what happens with miR-1246? it is a recent miRNA, primate specific, detected by sequencing in different studies (1,2,3). The counts related to these sequences are not so high, actually very low after normalization, but still are there. miRBase gives a precursor this region: chr2: 177465708-177465780 [-]\nFig 1: mir1246 We see that there is a repeat element (ERV, retrovirus) and also it is a pretty conserved region. Until here, everything allright. But, I realized some time ago, annotating some data that I had, that the mature miRNA annotates in other regions:\nchr:start-end strand type conservation chr13:21,186,304-21,186,473 + U2 human chr14:96,850,961-96,851,148 + U2 rhesus chr5:157,403,780-157,403,964 - U2 rhesus chr6:89,773,226-89,773,409 - U2 rhesus chr13:46,948,540-46,948,725 - U2 rhesus chr3:127,793,920-127,794,092 - U2 rhesus chr2:177,465,708-177,465,780 - miR-1246 rhesus,mouse,dog,elephant All of them are copies of a RNA repeat according RepBase, specifically the snRNA U2 class (150-200 nt). In addition, I got much more reads inside those (extra) locations than inside the annotated precursor (3 orders bigger). Furthermore, all of them had a peak in their coverage profile (fig 2).\nFig 2:Reads coverage of U2 The question that arises now: is this a real miRNA, or a sub-product, or both? with any function? Maybe there is more than one precursor, or maybe it is a miRNA-like snRNA. Moreover, the secondary structure of these U2 is very similar to a miRNA precursor hairpin (fig 3).\nFig 3:U2 secondary structure One cause of this annotation could be that the unique precursor conserved beyond primates is the one mentioned in miRBase, while the other U2 locations are primate-specific. Extra analyses should be done to reveal the real nature of this miRNA. Results suggest that, either the miRNA has more than one precursor, or a sub-product, or both.\nAs an extra-analysis, I took public data, KO Dicer and control, of HELA cells (GSM769512) to study the dependency od these sequences to DICER. You expect a decrease in the number of counts of miRNA sequences, between control and KO dicer. The exact miRNA sequence decrease 1/3 in KO dicer cells, assuming a Dicer dependency, and take this sequence as a real miRNA. But, we have a lot of other sequences in the U2 regions, but not in the annotated precursor, and only differ in one extra nucleotide (Adenosine) at the beginning (miR-1246: AAUGGAUUUUUGGAGCAGG and U2: AAAUGGAUUUUUGGAGCAGG).This sequence can be annotated as miR-1246 if you allow 1 mismatch in the alignment (the A nt). This sequence had the same counts in normal cells and KO cells, suggesting that sequences from U2 are not Dicer-dependent. Summarizing, we have the mature annotated miRNA mapping in all these positions, and in addition, we have other sequences (one nt longer), that only map in the U2 positions. So, how we can differentiate what proportion of sequences comes from the precursors and what comes from the other positions? Well, one possibility is to detect the precursor by PCR in your samples, to assume that at least it is there, or try to see whether the coverage in the different locations makes sense more with one scenario or another‚Ä¶Or maybe it is not a big deal, you have this small RNA, the question is whether it has any regulatory function or not.\nFrom here, we may agree that it is better to double-check what is happening when annotating small RNAs, because there are many possibilities to take a wrong conclusion if you only believe in a preliminary analysis. Nowadays, data is increasing a lot, and scientists need to make a bunch of assumptions to obtain something, but be careful with those assumptions (indeed, they are needed to evolve in science) because you may be missing something else or getting something wrong or wasting your time with experiments to corroborate your computational results.\nReferences\n[1] PMID:18583537\n‚ÄúMicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries‚Äù\nBar M, Wyman SK, Fritz BR, Qi J, Garg KS, Parkin RK, Kroh EM, Bendoraite A, Mitchell PS, Nelson AM, Ruzzo WL, Ware C, Radich JP, Gentleman R, Ruohola-Baker H, Tewari M\nStem Cells. 26:2496-2505(2008).\n[2] PMID:20300190\n‚ÄúCharacterization of the Melanoma miRNAome by Deep Sequencing‚Äù\nStark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, Whiteman DC, Parsons PG, Schmidt C, Sturm RA, Hayward NK\nPLoS One. 5:e9685(2010).\n[3] PMID:20459774\n‚ÄúUltra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls‚Äù\nWitten D, Tibshirani R, Gu SG, Fire A, Lui WO\nBMC Biol. 8:58(2010).\n","date":1369663982,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1369663982,"objectID":"b2a9c80c51f7796a868c0445fa40d3e5","permalink":"http://lpantano.github.io/post/legacy/2013-05-27-mirna-annotation-complex-scenarios/","publishdate":"2013-05-27T10:13:02-04:00","relpermalink":"/post/legacy/2013-05-27-mirna-annotation-complex-scenarios/","section":"post","summary":"Everybody who is working with microRNA knows about miRBase, it was the first miRNA catalogue. Everybody is using it to annotate small RNA sequences as miRNA or not. And it is great, and very helpfully‚Ä¶but there are some cases that we should investigate our results.\n","tags":["small RNA"],"title":"miRNA annotation: complex scenarios","type":"post"},{"authors":["Franc Llorens","M√≥nica Ba√±ez-Coronel","Lorena Pantano","Jose Antonio del R√≠o","Isidre Ferrer","Xavier Estivill","ÃÅ Eul√†lia Marti"],"categories":null,"content":"","date":1356998400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1356998400,"objectID":"23413f8e04e5bf03ec934351e87025ce","permalink":"http://lpantano.github.io/publication/llorens-2013/","publishdate":"2019-09-08T18:14:44.099339Z","relpermalink":"/publication/llorens-2013/","section":"publication","summary":"BACKGROUND: MicroRNAs (miRNAs) are short non-coding regulatory RNAs that control gene expression usually producing translational repression and gene silencing. High-throughput sequencing technologies have revealed heterogeneity at length and sequence level for the majority of mature miRNAs (IsomiRs). Most isomiRs can be explained by variability in either Dicer1 or Drosha cleavage during miRNA biogenesis at 5' or 3' of the miRNA (trimming variants). Although isomiRs have been described in different tissues and organisms, their functional validation as modulators of gene expression remains elusive. Here we have characterized the expression and function of a highly abundant miR-101 5'-trimming variant (5'-isomiR-101).  RESULTS: The analysis of small RNA sequencing data in several human tissues and cell lines indicates that 5'-isomiR-101 is ubiquitously detected and a highly abundant, especially in the brain. 5'-isomiR-101 was found in Ago-2 immunocomplexes and complementary approaches showed that 5'-isomiR-101 interacted with different members of the silencing (RISC) complex. In addition, 5'-isomiR-101 decreased the expression of five validated miR-101 targets, suggesting that it is a functional variant. Both the binding to RISC members and the degree of silencing were less efficient for 5'-isomiR-101 compared with miR-101. For some targets, both miR-101 and 5'-isomiR-101 significantly decreased protein expression with no changes in the respective mRNA levels. Although a high number of overlapping predicted targets suggest similar targeted biological pathways, a correlation analysis of the expression profiles of miR-101 variants and predicted mRNA targets in human brains at different ages, suggest specific functions for miR-101- and 5'-isomiR-101.  CONCLUSIONS: These results suggest that isomiRs are functional variants and further indicate that for a given miRNA, the different isomiRs may contribute to the overall effect as quantitative and qualitative fine-tuners of gene expression.","tags":["Amyloid beta-Protein Precursor","Amyloid beta-Protein Precursor: deficiency","Amyloid beta-Protein Precursor: genetics","Argonaute Proteins","Argonaute Proteins: metabolism","Cell Line","Cyclooxygenase 2","Cyclooxygenase 2: deficiency","Cyclooxygenase 2: genetics","DEAD-box RNA Helicases","DEAD-box RNA Helicases: metabolism","Dual Specificity Phosphatase 1","Dual Specificity Phosphatase 1: deficiency","Dual Specificity Phosphatase 1: genetics","Gene Expression Regulation","Gene Expression Regulation: genetics","Gene Silencing","Humans","MicroRNAs","MicroRNAs: genetics","MicroRNAs: metabolism","Myeloid Cell Leukemia Sequence 1 Protein","Polycomb Repressive Complex 2","Polycomb Repressive Complex 2: deficiency","Polycomb Repressive Complex 2: genetics","Proto-Oncogene Proteins","Proto-Oncogene Proteins c-bcl-2","Proto-Oncogene Proteins c-bcl-2: deficiency","Proto-Oncogene Proteins c-bcl-2: genetics","Proto-Oncogene Proteins: metabolism","RNA Isoforms","RNA Isoforms: genetics","RNA Isoforms: metabolism"],"title":"A highly expressed miR-101 isomiR is a functional silencing small RNA.","type":"publication"},{"authors":["Franc Llorens","Manuela Hummel","Lorena Pantano","Xavier Pastor","Ana Vivancos","Ester Castillo","Heidi Mattlin","Anna Ferrer","Matthew Ingham","Marc Noguera","Robert Kofler","Juliane C Dohm","Raquel Pluvinet","M√≤nica Bay√©s","Heinz Himmelbauer","Jos√© Antonio del Rio","Eul√†lia Mart√≠","Lauro Sumoy"],"categories":null,"content":"","date":1356998400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1356998400,"objectID":"949dcaf4bcf521514d358ab084c1f1c5","permalink":"http://lpantano.github.io/publication/llorens-2013-a/","publishdate":"2019-09-08T18:14:44.100255Z","relpermalink":"/publication/llorens-2013-a/","section":"publication","summary":"BACKGROUND: Epidermal Growth Factor (EGF) plays an important function in the regulation of cell growth, proliferation, and differentiation by binding to its receptor (EGFR) and providing cancer cells with increased survival responsiveness. Signal transduction carried out by EGF has been extensively studied at both transcriptional and post-transcriptional levels. Little is known about the involvement of microRNAs (miRNAs) in the EGF signaling pathway. miRNAs have emerged as major players in the complex networks of gene regulation, and cancer miRNA expression studies have evidenced a direct involvement of miRNAs in cancer progression.  RESULTS: In this study, we have used an integrative high content analysis approach to identify the specific miRNAs implicated in EGF signaling in HeLa cells as potential mediators of cancer mediated functions. We have used microarray and deep-sequencing technologies in order to obtain a global view of the EGF miRNA transcriptome with a robust experimental cross-validation. By applying a procedure based on Rankprod tests, we have delimited a solid set of EGF-regulated miRNAs. After validating regulated miRNAs by reverse transcription quantitative PCR, we have derived protein networks and biological functions from the predicted targets of the regulated miRNAs to gain insight into the potential role of miRNAs in EGF-treated cells. In addition, we have analyzed sequence heterogeneity due to editing relative to the reference sequence (isomiRs) among regulated miRNAs.  CONCLUSIONS: We propose that the use of global genomic miRNA cross-validation derived from high throughput technologies can be used to generate more reliable datasets inferring more robust networks of co-regulated predicted miRNA target genes.","tags":["Epidermal Growth Factor","Epidermal Growth Factor: pharmacology","Gene Silencing","Gene Targeting","Genomics","Genomics: methods","HeLa Cells","High-Throughput Nucleotide Sequencing","High-Throughput Nucleotide Sequencing: methods","Humans","MicroRNAs","MicroRNAs: genetics","Oligonucleotide Array Sequence Analysis","Oligonucleotide Array Sequence Analysis: methods","Sequence Analysis","RNA","Signal Transduction","Signal Transduction: drug effects","Signal Transduction: genetics","Transcription","Genetic","Transcription","Genetic: drug effects","Transcription","Genetic: genetics"],"title":"Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor.","type":"publication"},{"authors":null,"categories":null,"content":"I spent all my PhD working with small RNA sequences data. The main problem was, always those sequences that map in multiple locations, also denominated ambiguous sequences. From the very beginning, this made that pipelines remove this kind of sequences from the analysis, because you cannot assign them a unique location in the genome. But these sequences are interesting¬†to study, since many of them change in size, for instance. This complexity is due to repeats in the genome and the scenario I am talking about here it is shown in the following figure: ![]({{ site.url }}/assets/example1.png)\nEach color it would be a different sRNA, and the lines show the locations of each sRNA. There are location shared by some of the sRNAs, and you can easily transform this into a network of vertexes and edges, where vertexes are locations and edges, are their relationship coming from the sRNAs inside them. In this case it would generate three circles connected between them. And that it was I did with a real data set. I used igraph¬†in R to represent this with the help of this great¬†tutorial. The result is:\nIt is very easy to detect high complexity regions, where locations are connected because some sRNAs map to anywhere else. From here, you can add more information, as the average size of the sRNAs inside each location, or the expression (red: low, yellow:high). ![]({{ site.baseurl }}/assets/net-exp-3.png ‚Äúnetwork of sRNA complexity‚Äù) In a quick view you can check the complexity of your small RNA data and the expression associated. The code is published at Rpub repository.\n","date":1347984624,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1347984624,"objectID":"9a490262ad8b8633ad832568b5b92c5f","permalink":"http://lpantano.github.io/post/legacy/2012-09-18-visualizing-small-rna-mapping-complexity/","publishdate":"2012-09-18T12:10:24-04:00","relpermalink":"/post/legacy/2012-09-18-visualizing-small-rna-mapping-complexity/","section":"post","summary":"I spent all my PhD working with small RNA sequences data. The main problem was, always those sequences that map in multiple locations, also denominated ambiguous sequences. From the very beginning, this made that pipelines remove this kind of sequences from the analysis, because you cannot assign them a unique location in the genome. But these sequences are interesting¬†to study, since many of them change in size, for instance. This complexity is due to repeats in the genome and the scenario I am talking about here it is shown in the following figure: ![]({{ site.url }}/assets/example1.png)\n","tags":["annotation","small RNA"],"title":"visualizing small RNA mapping complexity","type":"post"},{"authors":null,"categories":null,"content":"One of my interest in science is finding new ways to visualize Big Data. Scientist are used to work with static visualization, that of course, is wonderful in the majority of the case. But it wouldn‚Äôt be better dynamic visualization for exploration? Play with your data, explore, and finally when you get that great figure that tell you everything you was looking for, you can export it to an image portable format.\nI played many time with javascript/HTML5 resources, but are no so easy to implement if you are not an expert, and some times, huge data makes difficult the easy interaction. Well, recently I found Polychart, is still in beta version, but I am using one of the feature they provide: Graph builder. And this is how it looks like after loading a file with 5000 rows and 37 columns:\nYou can make different type of charts, like boxplot, barplot, piechart (although aren‚Äôt well considered) etc. Also, you can customize titles and transform data. Quick complete for a beta version.\nFinally but not less important, it is free for academics. :)\n","date":1344972492,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1344972492,"objectID":"7dcfbbf40f0a029498ebc3442108f84b","permalink":"http://lpantano.github.io/post/legacy/2012-08-14-visualizing-science-is-also-cool-polychart/","publishdate":"2012-08-14T15:28:12-04:00","relpermalink":"/post/legacy/2012-08-14-visualizing-science-is-also-cool-polychart/","section":"post","summary":"One of my interest in science is finding new ways to visualize Big Data. Scientist are used to work with static visualization, that of course, is wonderful in the majority of the case. But it wouldn‚Äôt be better dynamic visualization for exploration? Play with your data, explore, and finally when you get that great figure that tell you everything you was looking for, you can export it to an image portable format.\n","tags":["viz"],"title":"Visualizing science is also cool @polychart","type":"post"},{"authors":null,"categories":null,"content":"How much keywords in bioinformatics has changed in the past 7 years?\nI did a small and quick experiment. I took the abstract of the papers published in Bioinformatics during Jan-2005 and during Jan-2012. Then I represented the words according to their frequency with the wordle tool. And the result was:\nWhat is main difference? There are new concepts, of course, but the main difference is the size of the word DATA and the word METHOD, as it happens in the real world, data increased a lot, so we put it much more in our work, and we need a lof of new methods, so we highlight this in our work.\n","date":1334328307,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1334328307,"objectID":"b51eb40285e6dea589f1a43b9bb7602f","permalink":"http://lpantano.github.io/post/legacy/2012-04-13-bionformatics-evolution-2005-2012/","publishdate":"2012-04-13T10:45:07-04:00","relpermalink":"/post/legacy/2012-04-13-bionformatics-evolution-2005-2012/","section":"post","summary":"How much keywords in bioinformatics has changed in the past 7 years?\nI did a small and quick experiment. I took the abstract of the papers published in Bioinformatics during Jan-2005 and during Jan-2012. Then I represented the words according to their frequency with the wordle tool. And the result was:\n","tags":["general"],"title":"Bionformatics evolution 2005-2012","type":"post"},{"authors":["M√≥nica Ba√±ez-Coronel","Silvia Porta","Birgit Kagerbauer","Elisabet Mateu-Huertas","Lorena Pantano","Isidre Ferrer","Manuel Guzm√°n","Xavier Estivill","Eul√†lia Mart√≠"],"categories":null,"content":"","date":1328054400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1328054400,"objectID":"7454e704fff6529eee10ea94919fecb2","permalink":"http://lpantano.github.io/publication/banez-coronel-2012/","publishdate":"2019-09-08T18:14:44.101205Z","relpermalink":"/publication/banez-coronel-2012/","section":"publication","summary":"Huntington's disease (HD) is an autosomal dominantly inherited disorder caused by the expansion of CAG repeats in the Huntingtin (HTT) gene. The abnormally extended polyglutamine in the HTT protein encoded by the CAG repeats has toxic effects. Here, we provide evidence to support that the mutant HTT CAG repeats interfere with cell viability at the RNA level. In human neuronal cells, expanded HTT exon-1 mRNA with CAG repeat lengths above the threshold for complete penetrance (40 or greater) induced cell death and increased levels of small CAG-repeated RNAs (sCAGs), of ‚âà21 nucleotides in a Dicer-dependent manner. The severity of the toxic effect of HTT mRNA and sCAG generation correlated with CAG expansion length. Small RNAs obtained from cells expressing mutant HTT and from HD human brains significantly decreased neuronal viability, in an Ago2-dependent mechanism. In both cases, the use of anti-miRs specific for sCAGs efficiently blocked the toxic effect, supporting a key role of sCAGs in HTT-mediated toxicity. Luciferase-reporter assays showed that expanded HTT silences the expression of CTG-containing genes that are down-regulated in HD. These results suggest a possible link between HD and sCAG expression with an aberrant activation of the siRNA/miRNA gene silencing machinery, which may trigger a detrimental response. The identification of the specific cellular processes affected by sCAGs may provide insights into the pathogenic mechanisms underlying HD, offering opportunities to develop new therapeutic approaches.","tags":["Biology","Gene expression","Genetics and Genomics","Genomics","Molecular Biology","Molecular cell biology","Nucleic acids","RNA","Research Article"],"title":"A Pathogenic Mechanism in Huntington's Disease Involves Small CAG-Repeated RNAs with Neurotoxic Activity.","type":"publication"},{"authors":["Lorena Pantano","Xavier Estivill","Eulalia Mart√≠"],"categories":null,"content":"","date":1320105600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1320105600,"objectID":"d30cf76bfa94a1f5e3c61f639b7e07bf","permalink":"http://lpantano.github.io/publication/pantano-2011/","publishdate":"2019-09-08T18:15:28.610452Z","relpermalink":"/publication/pantano-2011/","section":"publication","summary":"MOTIVATION: Recent progress in high-throughput sequencing technologies has largely contributed to reveal a highly complex landscape of small non-coding RNAs (sRNAs), including novel non-canonical sRNAs derived from long non-coding RNA, repeated elements, transcription start sites and splicing site regions among others. The published frameworks for sRNA data analysis are focused on miRNA detection and prediction, ignoring further information in the dataset. As a consequence, tools for the identification and classification of the sRNAs not belonging to miRNA family are currently lacking. RESULTS: Here, we present, SeqCluster, an extension of the currently available SeqBuster tool to identify and analyze at different levels the sRNAs not annotated or predicted as miRNAs. This new module deals with sequences mapping onto multiple locations and permits a highly versatile and user-friendly interaction with the data in order to easily classify sRNA sequences with a putative functional importance. We were able to detect all known classes of sRNAs described to date using SeqCluster with different sRNA datasets.","tags":["Animals","Humans","Mice","MicroRNAs","MicroRNAs: classification","Molecular Sequence Annotation","RNA","Sequence Analysis","Small Untranslated","Small Untranslated: chemistry","Small Untranslated: classification","Software","Transcriptome","selected"],"title":"A non-biased framework for the annotation and classification of the non-miRNA small RNA transcriptome.","type":"publication"},{"authors":["Eul√†lia Mart√≠","Lorena Pantano","M√≥nica Ba√±ez-Coronel","Franc Llorens","Elena Mi√±ones-Moyano","Sƒ∫via Porta","Lauro Sumoy","Isidre Ferrer","Xavier Estivill"],"categories":null,"content":"","date":1262304000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1262304000,"objectID":"5e9bd2832fba309a16cfba58c7398a05","permalink":"http://lpantano.github.io/publication/marti-2010/","publishdate":"2019-09-08T18:15:28.612616Z","relpermalink":"/publication/marti-2010/","section":"publication","summary":"Huntington disease (HD) is a neurodegenerative disorder that predominantly affects neurons of the forebrain. We have applied the Illumina massively parallel sequencing to deeply analyze the small RNA populations of two different forebrain areas, the frontal cortex (FC) and the striatum (ST) of healthy individuals and individuals with HD. More than 80% of the small-RNAs were annotated as microRNAs (miRNAs) in all samples. Deep sequencing revealed length and sequence heterogeneity (IsomiRs) for the vast majority of miRNAs. Around 8090% of the miRNAs presented modifications in the 3-terminus mainly in the form of trimming and/or as nucleotide addition variants, while the 5-terminus of the miRNAs was specially protected from changes. Expression profiling showed strong miRNA and isomiR expression deregulation in HD, most being common to both FC and ST. The analysis of the upstream regulatory regions in co-regulated miRNAs suggests a role for RE1-Silencing Transcription Factor (REST) and P53 in miRNAs downregulation in HD. The putative targets of deregulated miRNAs and seed-region IsomiRs strongly suggest that their altered expression contributes to the aberrant gene expression in HD. Our results show that miRNA variability is a ubiquitous phenomenon in the adult human brain, which may influence gene expression in physiological and pathological conditions.","tags":["selected"],"title":"A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing","type":"publication"},{"authors":["Lorena Pantano","Xavier Estivill","Eul√†lia Mart√≠"],"categories":null,"content":"","date":1262304000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1262304000,"objectID":"99214e280ef59fcb986d23bf4117078a","permalink":"http://lpantano.github.io/publication/pantano-2010/","publishdate":"2019-09-08T18:15:28.613997Z","relpermalink":"/publication/pantano-2010/","section":"publication","summary":"High-throughput sequencing technologies enable direct approaches to catalog and analyze snapshots of the total small RNA content of living cells. Characterization of high-throughput sequencing data requires bioinformatic tools offering a wide perspective of the small RNA transcriptome. Here we present SeqBuster, a highly versatile and reliable web-based toolkit to process and analyze large-scale small RNA datasets. The high flexibility of this tool is illustrated by the multiple choices offered in the pre-analysis for mapping purposes and in the different analysis modules for data manipulation. To overcome the storage capacity limitations of the web-based tool, SeqBuster offers a stand-alone version that permits the annotation against any custom database. SeqBuster integrates multiple analyses modules in a unique platform and constitutes the first bioinformatic tool offering a deep characterization of miRNA variants (isomiRs). The application of SeqBuster to small-RNA datasets of human embryonic stem cells revealed that most miRNAs present different types of isomiRs, some of them being associated to stem cell differentiation. The exhaustive description of the isomiRs provided by SeqBuster could help to identify miRNA-variants that are relevant in physiological and pathological processes. SeqBuster is available at http://estivilllab.crg.es/seqbuster.","tags":["bcbio-srnaseq","cell differentiation","computational biology","embryonic stem cells","embryonic stem cells cytology","embryonic stem cells metabolism","genetic variation","humans","micrornas","micrornas chemistry","micrornas metabolism","rna","selected","sequence analysis","software","srna-methods"],"title":"SeqBuster, a bioinformatic tool for the processing and analysis of small RNAs datasets, reveals ubiquitous miRNA modifications in human embryonic cells","type":"publication"},{"authors":["Florencio Varas","Matthias Stadtfeld","Luisa De Andres-Aguayo","Nimet Maherali","Alessandro di Tullio","Lorena Pantano","Cedric Notredame","Konrad Hochedlinger","Thomas Graf"],"categories":null,"content":"","date":1233446400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1233446400,"objectID":"83497e5dd976a2526119be07f43dd51d","permalink":"http://lpantano.github.io/publication/varas-2009/","publishdate":"2019-09-08T18:14:44.102764Z","relpermalink":"/publication/varas-2009/","section":"publication","summary":"Several laboratories have reported the reprogramming of mouse and human fibroblasts into pluripotent cells, using retroviruses carrying the Oct4, Sox2, Klf4, and c-Myc transcription factor genes. In these experiments the frequency of reprogramming was lower than 0.1% of the infected cells, raising the possibility that additional events are required to induce reprogramming, such as activation of genes triggered by retroviral insertions. We have therefore determined by ligation-mediated polymerase chain reaction (LM-PCR) the retroviral insertion sites in six induced pluripotent stem (iPS) cell clones derived from mouse fibroblasts. Seventy-nine insertion sites were assigned to a single mouse genome location. Thirty-five of these mapped to gene transcription units, whereas 29 insertions landed within 10 kilobases of transcription start sites. No common insertion site was detected among the iPS clones studied. Moreover, bioinformatics analyses revealed no enrichment of a specific gene function, network, or pathway among genes targeted by retroviral insertions. We conclude that Oct4, Sox2, Klf4, and c-Myc are sufficient to promote fibroblast-to-iPS cell reprogramming and propose that the observed low reprogramming frequencies may have alternative explanations.","tags":["Animals","Blotting","Cell Line","Computational Biology","Fibroblasts","Fibroblasts: cytology","Fibroblasts: virology","Genetic Vectors","Genetic Vectors: genetics","Humans","Kruppel-Like Transcription Factors","Kruppel-Like Transcription Factors: genetics","Mice","Octamer Transcription Factor-3","Octamer Transcription Factor-3: genetics","Pluripotent Stem Cells","Pluripotent Stem Cells: cytology","Pluripotent Stem Cells: metabolism","Pluripotent Stem Cells: virology","Polymerase Chain Reaction","Proto-Oncogene Proteins c-myc","Proto-Oncogene Proteins c-myc: genetics","Retroviridae","Retroviridae: genetics","SOXB1 Transcription Factors","SOXB1 Transcription Factors: genetics","Southern","mypapers"],"title":"Fibroblast-derived induced pluripotent stem cells show no common retroviral vector insertions.","type":"publication"},{"authors":["Lluis Armengol","Sergi Villatoro","Juan R. Gonzalez","Lorena Pantano","Manel Garc√°-Aragon√©s","Raquel Rabionet","Mario C√°ceres","Xavier Estivill"],"categories":null,"content":"","date":1230768000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1230768000,"objectID":"dd00880e167aafbcff4a5ff1dcf590f2","permalink":"http://lpantano.github.io/publication/armengol-2009/","publishdate":"2019-09-08T18:14:44.102232Z","relpermalink":"/publication/armengol-2009/","section":"publication","summary":"Background: Understanding the genetic contribution to phenotype variation of human groups is necessary to elucidate differences in disease predisposition and response to pharmaceutical treatments in different human populations. Methodology/Principal Findings: We have investigated the genome-wide profile of structural variation on pooled samples from the three populations studied in the HapMap project by comparative genome hybridization (CGH) in different array platforms. We have identified and experimentally validated 33 genomic loci that show significant copy number differences from one population to the other. Interestingly, we found an enrichment of genes related to environment adaptation (immune response, lipid metabolism and extracellular space) within these regions and the study of expression data revealed that more than half of the copy number variants (CNVs) translate into gene-expression differences among populations, suggesting that they could have functional consequences. In addition, the identification of single nucleotide polymorphisms (SNPs) that are in linkage disequilibrium with the copy number alleles allowed us to detect evidences of population differentiation and recent selection at the nucleotide variation level. Conclusions: Overall, our results provide a comprehensive view of relevant copy number changes that might play a role in phenotypic differences among major human populations, and generate a list of interesting candidates for future studies.","tags":null,"title":"Identification of Copy Number Variants Defining Genomic Differences among Major Human Groups","type":"publication"},{"authors":["Lorena Pantano","Llu√≠s Armengol","Sergi Villatoro","Xavier Estivill"],"categories":null,"content":"","date":1199145600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1199145600,"objectID":"62243057c0bcbf313a91b557b3609b8c","permalink":"http://lpantano.github.io/publication/pantano-2008/","publishdate":"2019-09-08T18:14:44.103418Z","relpermalink":"/publication/pantano-2008/","section":"publication","summary":"Background: The technological evolution of platforms for detecting genome-wide copy number imbalances has allowed the discovery of an unexpected amount of human sequence that is variable in copy number among individuals. This type of human variation can make an important contribution to human diversity and disease susceptibility. Multiplex Ligation-dependent Probe Amplification (MLPA) is a targeted method to assess copy number differences for up to 40 genomic loci in one single experiment. Although specific MLPA assays can be ordered from MRC-Holland (the proprietary company of the MLPA technology), custom designs are also developed in many laboratories worldwide. After our own experience, an important drawback of custom MLPA assays is the time spent during the design of the specific oligonucleotides that are used as probes. Due to the large number of probes included in a single assay, a number of restrictions need to be met in order to maximize specificity and to increase success likelihood. Results: We have developed a web tool for facilitating and optimising custom probe design for MLPA experiments. The algorithm only requires the target sequence in FASTA format and a set of parameters, that are provided by the user according to each specific MLPA assay, to identify the best probes inside the given region. Conclusion: To our knowledge, this is the first available tool for optimizing custom probe design of MLPA assays. The ease-of-use and speed of the algorithm dramatically reduces the turn around time of probe design. ProSeeK will become a useful tool for all laboratories that are currently using MLPA in their research projects for CNV studies.","tags":["*Internet","*User-Computer Interface","Algorithms","DNA Probes/*chemical synthesis","Humans","Nucleic Acid Amplification Techniques/*methods","algorithms","dna probes","dna probes chemical synthesis","humans","internet","nucleic acid amplification techniques","nucleic acid amplification techniques methods","user computer interface"],"title":"ProSeeK: A web server for MLPA probe design","type":"publication"},{"authors":["Priscila Grynberg","Thomas Abeel","Pedro Lopes","Geoff Macintyre","Lorena Pantano"],"categories":null,"content":"","date":1167609600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1167609600,"objectID":"0d99c806f0c315f033ee142043aa5f36","permalink":"http://lpantano.github.io/publication/grynberg-2007/","publishdate":"2019-09-08T18:14:44.104084Z","relpermalink":"/publication/grynberg-2007/","section":"publication","summary":"Abstract In this meeting report we give an overview of the 3rd International Society for Computational Biology Student Council Symposium. Furthermore, we explain the role of the Student Council and the symposium series in the context of large, international conferences.","tags":["iscb"],"title":"Highlights from the Third International Society for Computational Biology Student Council Symposium at the Fifteenth Annual International Conference on Intelligent Systems for Molecular Biology","type":"publication"},{"authors":["Razi Khaja","Junjun Zhang","Jeffrey R MacDonald","Yongshu He","Ann M Joseph-George","John Wei","Muhammad A Rafiq","Cheng Qian","Mary Shago","Lorena Pantano","Hiroyuki Aburatani","Keith Jones","Richard Redon","Matthew Hurles","Lluis Armengol","Xavier Estivill","Richard J Mural","Charles Lee","Stephen W Scherer","Lars Feuk"],"categories":null,"content":"","date":1136073600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1136073600,"objectID":"fc310f47066732fc532d6329fbd668b0","permalink":"http://lpantano.github.io/publication/khaja-2006/","publishdate":"2019-09-08T18:14:44.104706Z","relpermalink":"/publication/khaja-2006/","section":"publication","summary":"Numerous types of DNA variation exist, ranging from SNPs to larger structural alterations such as copy number variants (CNVs) and inversions. Alignment of DNA sequence from different sources has been used to identify SNPs and intermediate-sized variants (ISVs). However, only a small proportion of total heterogeneity is characterized, and little is known of the characteristics of most smaller-sized (1.5 million SNPs. Some differences were simple insertions and deletions, but in regions containing CNVs, segmental duplication and repetitive DNA, they were more complex. Our results uncover substantial undescribed variation in humans, highlighting the need for comprehensive annotation strategies to fully interpret genome scanning and personalized sequencing projects.","tags":["*Genetic Variation","*Genome","Base Sequence","DNA/genetics","Fluorescence","Genomics","Human","Humans","In Situ Hybridization","Polymerase Chain Reaction","Sequence Alignment","base sequence","dna","dna genetics","fluorescence","genetic variation","genome","genomics","human","humans","polymerase chain reaction","sequence alignment","situ hybridization"],"title":"Genome assembly comparison identifies structural variants in the human genome.","type":"publication"}]